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Abstract
Animal African Trypanosomiasis (AAT) is a debilitating livestock disease prevalent across
sub-Saharan Africa, a main cause of which is the protozoan parasite Trypanosoma congo-
lense. In comparison to the well-studied T. brucei, there is a major paucity of knowledge
regarding the biology of T. congolense. Here, we use a combination of omics technologies
and novel genetic tools to characterise core metabolism in T. congolense mammalian-infec-
tive bloodstream-form parasites, and test whether metabolic differences compared to T.
brucei impact upon sensitivity to metabolic inhibition. Like the bloodstream stage of T. bru-
cei, glycolysis plays a major part in T. congolense energy metabolism. However, the rate of
glucose uptake is significantly lower in bloodstream stage T. congolense, with cells remain-
ing viable when cultured in concentrations as low as 2 mM. Instead of pyruvate, the primary
glycolytic endpoints are succinate, malate and acetate. Transcriptomics analysis showed
higher levels of transcripts associated with the mitochondrial pyruvate dehydrogenase com-
plex, acetate generation, and the glycosomal succinate shunt in T. congolense, compared
to T. brucei. Stable-isotope labelling of glucose enabled the comparison of carbon usage
between T. brucei and T. congolense, highlighting differences in nucleotide and saturated
fatty acid metabolism. To validate the metabolic similarities and differences, both species
were treated with metabolic inhibitors, confirming that electron transport chain activity is not
essential in T. congolense. However, the parasite exhibits increased sensitivity to inhibition
of mitochondrial pyruvate import, compared to T. brucei. Strikingly, T. congolense exhibited
significant resistance to inhibitors of fatty acid synthesis, including a 780-fold higher EC50 for
the lipase and fatty acid synthase inhibitor Orlistat, compared to T. brucei. These data high-
light that bloodstream form T. congolense diverges from T. brucei in key areas of metabo-
lism, with several features that are intermediate between bloodstream- and insect-stage T.
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brucei. These results have implications for drug development, mechanisms of drug resis-
tance and host-pathogen interactions.
Author summary
Animal African Trypanosomiasis (AAT), also known as Nagana, is a devastating disease
affecting livestock across sub-Saharan Africa. AAT is primarily caused by the parasite Try-
panosoma congolense, yet our biological knowledge about this pathogen is poor, especially
compared to the related species T. brucei, subspecies of which cause the human disease
Sleeping Sickness. Understanding the core metabolism of T. congolense is crucial in order
to gain insights into the infection biology of this important pathogen, as well as providing
the potential to identify new drug targets. In this work, we addressed the lack of knowl-
edge concerning T. congolense by carrying out a comprehensive analysis of core metabo-
lism, and comparing the data to T. brucei. We then used the findings of metabolic
differences to predict differential sensitivity to inhibitors of metabolic function. We show
that unlike T. brucei, where glucose metabolism leads to high levels of pyruvate excretion,
T. congolense metabolises glucose to other end-products, namely succinate, malate and
acetate. Moreover, there are pronounced differences in the way T. congolense uses glucose
to feed into other areas of metabolism. Further analysis also suggests that T. congolense
mostly scavenges lipids and fatty acids, rather than synthesising them de novo. To validate
these findings, we confirm that T. congolense is differentially susceptible to metabolic
inhibitors compared to T. brucei, and that, in particular, T. congolense is significantly less
sensitive to inhibitors of fatty acid synthesis. Our study provides a foundation of func-
tional metabolic knowledge on T. congolense, with insights into how this parasite funda-
mentally differs from T. brucei.
Introduction
The hemoflagellate protozoan parasite Trypanosoma congolense is a primary causative agent of
animal African trypanosomiasis (AAT), which can also be caused by T. vivax and T. brucei [1].
AAT is one of the most important livestock diseases across sub-Saharan Africa and accounts
for livestock deaths in excess of 3 million annually, with up to 120 million cattle at risk [2–4].
Current methods of disease control centre around chemotherapy and prophylaxis (reviewed
in [3]), but the very few available veterinary trypanocidal drugs have been used extensively for
decades, resulting in resistance and inadequate protection [5–8]. In contrast to T. brucei [9],
the resistance mechanisms of T. congolense are still poorly understood [10]. As such, there is a
critical need for the development of new and improved chemotherapeutics to manage AAT
[3,11], and furthering our knowledge of how T. congolense develops resistance to drugs can
facilitate optimising the lifetime of both existing and new drugs.
Most of our biological understanding of African trypanosomes derives from studies on T.
brucei, subspecies of which (T. b. gambiense and T. b. rhodesiense) cause Human African Try-
panosomiasis (HAT) [12]. The ability to culture both procyclic (PCF; tsetse fly) and blood-
stream (BSF; mammalian) forms of T. brucei in vitro, combined with its tractability with
respect to genetic manipulation, have enabled extensive study of this species at a molecular
level [13,14]. In stark contrast, very few T. congolense strains are amenable to continuous BSF
culture, with a single strain (IL3000) used in most studies [15]. Whilst genetic modification
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has been feasible in PCF stage T. congolense for some time, routine BSF transfection has only
recently become possible [16–18]. Additionally, although T. congolense exhibits a superficially
similar morphology and life cycle to T. brucei [19,20], emerging evidence increasingly suggests
that T. brucei, T. congolense and T. vivax exhibit some profound differences at the genomic
level [21–25], including in genes and phenotypes of direct relevance to metabolism, infection
biology and disease epidemiology. For example, T. brucei has an elaborate nucleoside trans-
porter lineage, whilst T. congolense has instead diversified its nucleobase transporter lineage
[21]. There is a lack of understanding to what extent these genetic differences translate into
biological differences, including with respect to metabolism.
Understanding metabolism is critical to identifying how pathogens survive and thrive in
the varying host environments they encounter, as well as being a means of identifying drug tar-
gets, elucidating modes of drug action and mechanisms of drug resistance [26–28]. T. brucei
metabolism has been extensively studied, aided by the application of technologies such as liq-
uid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR)
spectroscopy (reviewed in detail by [29,30]), which enable global profiling of the cellular
metabolome.
The BSF stage of T. brucei utilizes the high levels of glucose that are available in the mam-
malian bloodstream, and depends almost exclusively on the glycolytic pathway to generate
ATP [31]. The first seven steps of glycolysis are enclosed in a specialized organelle, the glyco-
some, which maintains its own ATP/ADP and NAD/NADH balance, allowing glycolysis to
proceed at an extraordinarily high rate in comparison to most other eukaryotic cells [32]. The
endpoint of glycolysis, pyruvate, is a waste product of T. brucei, and the majority is excreted
from the cell in large quantities. However, small amounts of pyruvate are further metabolized
in the mitochondrion to acetate by pyruvate dehydrogenase (PDH) and acetate:succinate CoA
transferase (ASCT), a secondary, yet essential pathway [33]. The acetate generated from this
pathway is utilized, at least partially, for the de novo synthesis of fatty acids [34]. Indeed, both
BSF and PCF T. brucei are highly sensitive to the lipase and fatty acid synthase inhibitor Orli-
stat [35].
Conversely, in the absence of blood meals, glucose is scarce in the tsetse fly midgut [36],
and the main energy source of PCF T. brucei is L-proline. Its catabolism leads to production of
acetate, succinate and L-alanine in PCF, which have a more developed and active mitochon-
drion than BSF (including an active respiratory chain capable of generating ATP, which is
inactive in BSF T. brucei [37]). Until recently, it was thought that PCF T. brucei did not exhibit
an active citric acid (TCA) cycle, although recent data have shown that TCA intermediates
such as succinate and 2-oxoglutarate can stimulate PCF T. brucei growth [38–40].
Among the glycolytic enzymes, T. brucei expresses three isoforms of phosphoglycerate
kinase (PGK), which catalyze the conversion of 1,3-bisphosphoglycerate to 3-phosphoglycerate
[41]. These are developmentally regulated, with the major isoform in BSF parasites present in
the glycosome (PGK-C), whilst the primary PCF isoform is found in the cytosol (PGK-B) [42].
The localization of PGK-B in the PCF cytosol is thought to result in an ATP/ADP imbalance
in the glycosome, which is rectified by upregulating the glycosomal “succinate shunt”, a path-
way that includes the ATP-generating phosphoenolpyruvate carboxykinase (PEPCK)- and
pyruvate phosphate dikinase (PPDK)-mediated conversion of phosphoenolpyruvate (PEP) to
oxaloacetate and pyruvate respectively [42,43]. Succinate shunt activity, combined with amino
acid metabolism, results in the excretion of high levels of succinate in PCF T. brucei [44].
Stable isotope labelling data has revealed that BSF T. brucei utilize D-glucose to a greater
extent than first realized, with its carbons disseminating into amino acid, lipid and nucleotide
metabolism [45]. This study also showed that some of the succinate and malate excreted from
BSF T. brucei originates from glycolysis and that, unexpectedly, inhibition of PEPCK is lethal
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for this life-cycle stage [45]. It has also been shown that acetate production is essential to BSF
T. brucei, in particular for the synthesis of fatty acids (FAs) [33]. Acetate excretion, as well as
that of succinate and malate, is negligible in BSF T. brucei compared to that of pyruvate and L-
alanine.
In contrast to T. brucei, the literature on metabolism in T. congolense is scarce. More than
half a century ago it was suggested that BSF T. congolense has a significantly lower rate of glu-
cose consumption compared to BSF T. brucei [46]. Furthermore, pyruvate is not the main gly-
colytic end product and instead, acetate and succinate are excreted at high levels, indicative of
metabolism more akin to PCF T. brucei [46]. Further work has revealed additional differences
that support this hypothesis [47–49]. For example, BSF T. congolense primarily express cyto-
solic PGK-B, rather than glycosomal PGK-C [49]. Transmission electron microscopy has also
revealed a more developed mitochondrion in BSF T. congolense, with visible cristae, suggesting
that mitochondrial energy metabolism could play a more prominent role in BSF T. congolense
[50]. The high levels of acetate excretion first shown by Agosin & Von Brand [46] are consis-
tent with this hypothesis. However, other studies have shown that BSF T. congolense is sensitive
to inhibitors of Trypanosome Alternative Oxidase (TAO), including salicylhydroxamide
(SHAM); and is insensitive to cyanide, suggesting that, as for BSF T. brucei, TAO is the sole
terminal oxidase, responsible for reoxidising glycerol 3-phosphate, in BSF T. congolense [51–
54]. Notably, nitroblue tetrazolium staining indicates the presence of NADH dehydrogenase
(complex I) activity in BSF T. congolense [51]. However, to date, no studies have assessed BSF
T. congolense sensitivity to chemical inhibition of the electron transport chain, or the F1Fo-
ATPase.
Post-genomic technologies allow for the generation of large datasets that enable analysis of
cellular processes on a systems scale, including metabolomics and transcriptomics. Integration
of these data can provide a detailed snapshot of cell metabolism at the transcript and metabo-
lite levels and help to dissect differences between species or conditions in unprecedented detail
[55]. Furthermore, this knowledge can aid in prediction and understanding of drug efficacy
and mode of action.
This study aimed to generate the first comprehensive overview of the metabolome of BSF
T. congolense IL3000 parasites, allowing a global metabolic comparison of differences between
T. congolense and T. brucei. Glycolytic metabolism in BSF T. congolense appears to be similar
to PCF T. brucei, particularly in terms of metabolic outputs and gene expression. However,
there are pronounced differences in parasite reliance on exogenous amino acids as well as car-
bon dissemination into pathways involved in nucleotide and lipid metabolism, as shown by
stable isotope-labelled metabolomics. Using these data, we further validated these metabolic
differences in T. congolense by pharmacological inhibition, which highlighted increased sensi-
tivity to inhibition of mitochondrial pyruvate uptake, as well as significant resistance to inhibi-
tion of fatty acid synthesis, tested using inhibitors of fatty acid synthase and acetyl-coA
synthetase. Taken together, these results suggest that T. congolense and T. brucei differ in some
fundamental aspects of their core metabolism, which may have important implications for
their interactions with the mammalian host, as well as potentially impacting upon drug
sensitivity.
Results
Comparative RNA-sequencing of T. congolense and T. brucei
To compare BSF T. congolense and T. brucei transcriptomes, RNAseq analysis was carried out
on parasites cultured in vitro (sampled from actively dividing cultures grown to densities of
1.8–2.0 × 106 cells/mL) and trypanosome samples isolated from infected mice at first peak
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parasitaemia (107 cells/mL; ex vivo; Fig 1). T. congolense (IL3000) and pleomorphic T. brucei
(STIB 247) in vitro and ex vivo samples were prepared, in order to assess similarities and differ-
ences between trypanosomes grown in culture and those from an infection (Fig 1A and 1B),
and to compare and contrast the transcriptome across the species (Fig 1C and 1D). Sequencing
data were aligned to the respective genome sequences with a mean overall alignment rate of
88.8 ± 6.5% and 92.6 ± 2.0% for T. brucei and T. congolense reads, respectively. The lower
alignment rate for T. brucei was likely due to the TREU 927 reference genome having a differ-
ent VSG repertoire than STIB 247. Resultant files were sorted and filtered for quality and read
counts were normalised using transcripts per million (TPM) [56]. Orthologues were inferred
between the species using Orthofinder [57], in order to directly compare TPM values for 1-to-
1 orthologues, as well as sum-of-TPM values for groups containing families of paralogues (e.g.
hexose transporters). These normalised read counts are henceforth referred to as orthoTPM
values (S1 Table). The Orthofinder dataset (S2 Table) consisted of 6,677 orthogroups (denoted
with the prefix “TbTc_”), of which 5,398 (80.84%) were 1-to-1 orthologues. The Orthofinder
tool was also used to predict genes only present in one of the two species (S2 Table).
There are several metabolic genes that are not present in the T. congolense genome, includ-
ing a putative delta-4 desaturase (Tb927.10.7100), a succinate dehydrogenase subunit (SDH11;
Tb927.8.6890) and mitochondrial pyruvate carrier 1 (MPC1; Tb927.9.3780). These genes are
encoded in regions exhibiting high levels of synteny between the species (S1 Fig) and thus
seem likely to represent genuine deletions in T. congolense. Furthermore, guanine deaminase
(GDA; Tb927.5.4560) was not identified in the T. congolense genome (S2 Table). Although the
GDA locus is subtelomeric in the T. brucei genome, and these regions are not syntenic with T.
congolense, sequences matching GDA could not be found either in the assembled genome or
the available unassembled contigs. Therefore, the most parsimonious explanation is that GDA
is also not encoded in the T. congolense genome. Based on the redundancy in trypanosomal
purine salvage pathways, it is highly unlikely that GDA would be essential in BSF T. brucei
[58].
Differences between four sample groups were assessed based on orthoTPM values (Fig 1;
full dataset in S1 Table). There was a strong intra-species correlation between the in vitro and
ex vivo transcriptomes (Pearson correlation coefficient, T. congolense (ρ) = 0.914, Fig 1A; T.
brucei ρ = 0.838, Fig 1B), showing that in vitro-derived BSF T. congolense and T. brucei closely
resemble parasites isolated from infections at the transcriptome level. Furthermore, although
correlations between species in the same condition were also high (ex vivo: ρ = 0.622, Fig 1C;
in vitro: ρ = 0.614, Fig 1D), the reduced correlation coefficient values do indicate a degree of
transcriptional differences between the species.
To compare data from this study to BSF T. congolense transcriptomics data generated by
Silvester et al. at ascending and peak parasitaemia [59], TPM values for each annotated T. con-
golense gene were compared directly (S2 Fig and S1 Table). There was good correlation
between both in vitro and ex vivo T. congolense BSF datasets and the data from Silvester et al.
(ρ> 0.85, S2 Fig), with highest correlation between the ex vivo and ascending data (ρ = 0.905,
S2 Fig), albeit the correlation between the ‘ascending’ and ‘peak parasitaemia’ in Silvester et al.
was higher (ρ = 0.988, S2 Fig).
T. congolense metabolite consumption and output
Global metabolite (metabolomics) analysis of in vitro culture supernatant samples provides a
detailed insight into the metabolic inputs and outputs of cultured cells [60]. However, high lev-
els of medium components can often mask subtle but significant changes in culture medium
composition over time. To counteract this, a modified culture medium was designed for T.
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congolense strain IL3000, based on previously published medium formulations (Steketee’s con-
golense medium, SCM-3; for details see Materials and Methods) [17,18].
A BSF T. congolense IL3000 time course was initiated, with cells isolated during mid-expo-
nential growth phase inoculated into fresh SCM-3 medium (0 h time point). Culture superna-
tant samples were collected at 0, 8, 24, 32, 48 and 56 hours (n = 4 at each time point) and
metabolites extracted for LC-MS analysis.
A total of 290 putative metabolites were detected across all samples (207 after removing
putative metabolites that did not map to metabolic pathways, e.g. peptides and medium com-
ponents), of which 37 were matched to an authentic standard to confidently predict their iden-
tity (S3 Table). Of the 207 metabolites in the final dataset, 100 were putatively annotated as
lipids. Annotations of putative mono- and poly-unsaturated fatty acids are of lower confidence
Fig 1. Overview of comparative transcriptomics analysis of T. brucei and T. congolense, isolated from ex vivo and in vitro
conditions. RNAseq data from T. congolense (IL3000) and T. brucei (STIB 247) in both in vitro and ex vivo (from mouse
infections) conditions were aligned to the species’ respective reference genomes and read counts were normalised by the
transcripts per million (TPM) method. To directly compare the species, a pseudogenome was generated using the
Orthofinder tool [57]. TPM values from the 4 sample groups were plotted against each other to analyse correlation between
conditions (A and B) and between species in the same conditions (C and D). Correlation was assessed using both Pearson
correlation (Pearson’s r) and Spearman’s rank correlation coefficients.
https://doi.org/10.1371/journal.ppat.1009734.g001
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due to the challenges of identifying these metabolite species using this LC-MS platform (see
Materials and Methods for details).
80 of the 207 putative metabolites were significantly altered across the dataset (false discov-
ery rate-adjusted p<0.05; one-way repeated measures ANOVA; Fig 2A and S3 Table). To ana-
lyse metabolites undergoing similar changes, K-means clustering with Pearson correlation
coefficient as the similarity metric was used, highlighting seven clusters with two clusters of
particular interest: one containing metabolites that accumulated over time, and the other con-
taining metabolites depleted over time (Fig 2A). Log2 fold change (log2 FC) between the first
and final time points (0 and 56 h, respectively) was also calculated for each metabolite (S3
Table).
Glucose, the primary energy source for T. brucei, whilst clearly consumed, was not fully
depleted after 56 hours in T. congolense culture (log2 FC: -0.76; Figs 2A and 3A), in contrast to
T. brucei, where 10 mM glucose is consumed by the same time-point [60]. Ribose, glucos-
amine, inosine and threonine were similarly depleted in T. congolense culture (log2 FC: -0.78,
-0.97, -2.82 and -0.89, respectively).
In contrast, a number of metabolites accumulated in the medium (Fig 2A). The most signif-
icant of these were guanine (log2 FC: 6.34; Fig 2A), succinate (log2 FC: 5.60; Figs 2A and 3B)
and (S)-malate (malate, log2 FC: 1.37; Figs 2A and 3B). Interestingly, pyruvate (log2 FC: 0.24;
Fig 3B) was not excreted at the high levels relative to starting concentration, in contrast to BSF
T. brucei culture where pyruvate secretion is consistently observed in both HMI-11 and in
Creek’s Minimal medium (CMM) [60]. Instead, succinate and malate appear to be the primary
glycolytic outputs from BSF T. congolense, which is similar to PCF T. brucei. Elevated levels of
2-oxoglutarate and a metabolite putatively identified as 2-oxoglutaramate were observed,
which potentially originate from alanine aminotransferase activity using L-glutamate and L-
glutamine, respectively, as substrates [45,61]. Moreover, a significant build-up of N6-Acetyl-L-
lysine (log2 FC: 6.30) was observed (Fig 2B). Whilst the low molecular weight of acetate means
it could not be detected by the LC-MS platform used, concentrations of this molecule were
measured directly using an acetate assay in samples taken at the same time points from four
independent cultures, which confirmed high levels of acetate excretion by BSF T. congolense
(Fig 3F).
Other notable observations included the depletion of several putatively identified lysopho-
sphatidylcholine species at 56 hours (Fig 2A and S3 Table), as seen in T. brucei [60], coincident
with increased medium levels of sn-glycero-3-phosphocholine, choline and choline phosphate,
indicating lyso-phospholipase activity where the charged headgroup moiety of a lyso-species is
cleaved from its bound fatty acid [62]. However, given the putative nature of these fatty acid
annotations, we could not confidently establish the origin of the elevated choline-related
metabolites. In addition, tryptophan (log2 FC: -0.74; S3 Table) was significantly consumed
(p = 0.042), in contrast with cysteine (log2 FC: -0.07; p> 0.05), despite the latter being essential
to T. brucei [63] (S3 Table).
The log2 metabolite fold changes after 56 hours of culture of T. congolense were compared
to those of T. brucei grown in HMI-11 (Fig 2B) [60]. A total of 90 metabolites were identified
in both datasets, with some showing divergence between the two species (Fig 2B). Several
metabolites only accumulated in T. brucei supernatant, in particular pyruvate, D-glycerate,
2-oxoglutarate and hydroxydodecanoic acid (Fig 2B). Conversely, succinate, N6-acetyl-L-
lysine, 4-hydroxy-4-methylglutamate, N6,N6,N6-trimethyl-L-lysine and choline only accumu-
lated in T. congolense supernatant (Fig 2B). Whilst cystine (Fig 2B; 12) was depleted in T. bru-
cei samples, this metabolite remained unchanged in those from T. congolense.
In summary, whilst core elements of metabolism have been conserved between BSF T. con-
golense and T. brucei, several pronounced differences in T. congolense metabolism were
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Fig 2. Analysis of supernatant metabolites after T. congolense culture. A heatmap covering the 80 putative medium components judged to be
significantly altered after 56 hours of in vitro cell culture containing T. congolense strain IL3000, as calculated by a one-way repeated measures
ANOVA (P< 0.05). Peak abundances were log transformed and mean centred and metabolites were clustered based on Pearson correlation. Two
clusters of interest were identified, which are shown in a larger format on the right. Metabolites in the top cluster were observed to increase
significantly over time, whilst those in the bottom cluster decreased. Metabolite names followed by {�} were matched to an authentic standard and all
other identifications are putative based on mass, retention time and formula. B) Comparison of metabolite changes in medium supernatants after 56
hours between T. brucei [60] and T. congolense (S3 Table). Relative changes in metabolite abundance were calculated as log2 fold change of 56 h vs 0 h
and metabolites exhibiting differences between the species are listed next to the figure.
https://doi.org/10.1371/journal.ppat.1009734.g002
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Fig 3. Energy metabolism in T. congolense. A-E) Supernatant metabolomics analysis of metabolites involved in glycolytic metabolism in T. congolense. Grey bars
indicate a negative medium control incubated for 56 hours. F) A commercial kit was used to measure acetate concentration during T. congolense culture, with
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identified based solely on metabolic input and output in in vitro culture. An integrated analysis
of the metabolomic and transcriptomic datasets was then undertaken in order to further define
the metabolic differences between the two species.
Energy metabolism
As described above, RNA sequencing and culture supernatant metabolomics provided initial
indications that BSF T. congolense energy metabolism, specifically with respect to glucose
usage, diverges substantially from that of BSF T. brucei (simplified map of glycolysis depicted
in Fig 3G). To dissect metabolic differences at the transcriptome level, pathway analysis was
carried out using the TrypanoCyc database [64], which contains 186 manually curated path-
ways covering 288 genes or groups of multi-copy genes (S4 Table). These analyses showed
broadly similar levels of gene expression of glycolytic components between BSF T. brucei and
T. congolense (Fig 3G and 3I). However, the T. brucei ex vivo samples displayed a more distinct
expression profile, with low transcript abundances for most glycolytic components compared
to all sample groups. This is most likely the result of cells being sampled near peak parasitae-
mia, and as the pleomorphic strain STIB 247 was used, having a higher proportion of tsetse-
transmissible, quiescent short stumpy forms–consistent with this there was elevated expression
of stumpy markers such as the PAD array (TbTc_0074), PIP39 (TbTc_0700) and reduced
expression of RBP10 (TbTc_0619) (S1 Table) [65–67].
Transcripts associated with gluconeogenesis, the succinate shunt, and the acetate genera-
tion pathway were increased in abundance in BSF T. congolense under both in vitro and ex
vivo conditions compared to BSF T. brucei. Key examples of this are PPDK, PEPCK, glycoso-
mal malate dehydrogenase (gMDH) and two subunits of pyruvate dehydrogenase (PDH) (Fig
3I). PPDK was previously reported to be expressed in BSF T. congolense, but not in BSF T. bru-
cei [47], and it may be assumed that the enzyme serves a similar function in BSF T. congolense
as it does in PCF T. brucei; primarily in a glycolytic role to maintain ATP/ADP balance in the
glycosome. The high levels of gMDH expression in BSF T. congolense contrasts with BSF T.
brucei, where gMDH expression is reported to be mostly absent, and cytosolic MDH (cMDH)
is the major isoform [68]. The RNAseq analysis also supports a previous study showing high
levels of glycerol kinase expression in BSF T. congolense [48].
To test whether elevated levels of succinate and malate seen in T. congolense supernatant
medium samples originated from glucose, LC-MS analysis using 13C-U-D-glucose was carried
out on intracellular metabolites isolated from in vitro-cultured cells. Stable isotope analysis has
provided valuable insights into T. brucei central carbon metabolism [45], and generating T.
congolense datasets enabled comparative analysis of glucose catabolism (albeit with an
supernatant samples analysed at the same time points as the supernatant metabolomics experiment. G) A simplified overview of the glycolytic pathway. Numbers refer to
the following proteins: 1, hexokinase; 2, glucose 6-phosphate isomerase; 3a, phosphofructokinase; 3b, fructose-1,6-bisphosphatase; 4, aldolase; 5, triosephosphate
isomerase; 6, glycerol 3-phosphate dehydrogenase; 7, glycerol kinase; 8, glyceraldehyde 3-phosphate dehydrogenase; 9, phosphoglycerate kinase; 10, phosphoglycerate
mutase; 11, enolase; 12, phosphenolpyruvate carboxykinase; 13, malate dehydrogenase; 14, fumarate hydratase; 15, NADH-dependent fumarate reductase; 16, pyruvate
kinase; 17, alanine aminotransferase; 18, pyruvate dehydrogenase complex; 19, acetate:succinate CoA-transferase and acetyl-CoA thioesterase. H) Tracing glucose
derived carbon usage through glycolytic metabolism. T. congolense were incubated with a 50:50 mix of 12C-D-glucose:13C-U-D-glucose before cell pellets were isolated
for metabolomics analysis. Results were compared to those generated in T. brucei by Creek and colleagues [45]. Colours indicate the number of 13C atoms in each
metabolite. I) Comparative analysis of transcript level activity of glycolysis in T. brucei and T. congolense from both in vitro and ex vivo conditions. Gene IDs: HK1 & 2,
hexokinase, TbTc_0341; GPI, glucose 6-phosphate isomerase, TbTc_1840; PFK, phosphofructokinase, TbTc_1399; ALDA, aldolase, TbTc_0358; TPI, Triosephosphate
isomerase, TbTc_1075; GPDH, glycerol 3-phosphate dehydrogenase, TbTc_2722; GK, glycerol kinase, TbTc_0392; GAPDH, glyceraldehyde 3-phosphate
dehydrogenase, TbTc_0377; PGK, phosphoglycerate kinase, TbTc_6030; PGKA, phosphoglycerate kinase A, TbTc_0241; PGKB/C, phosphoglycerate kinase B & C,
TbTc_0240; PGM, phosphoglycerate mutase, TbTc_5039; ENO1, enolase, TbTc_0465; ENO, putative, enolase, putative, TbTc_3614; PK1, pyruvate kinase 1, TbTc_0372;
FBPase, fructose-1,6-bisphosphatase, TbTc_1967; PEPCK, phosphoenolpyrvuate carboxykinase, TbTc_0348; gMDH, glycosomal malate dehydrogenase, TbTc_0642;
FH, fumarate hydratase, TbTc_0242; Frd, NADH-dependent fumarate reductase, TbTc_0141; PPDK, pyruvate phosphate dikinase, TbTc_1304; AAT, alanine
aminotransferase, TbTc_0675; PDH E1α, pyruvate dehydrogenase E1 alpha subunit, TbTc_4169; PDH E1β, pyruvate dehydrogenase E1 beta subunit, TbTc_5437.
https://doi.org/10.1371/journal.ppat.1009734.g003
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unavoidable difference in medium supplementation of goat serum for T. congolense, rather
than foetal bovine serum for T. brucei).
BSF T. congolense was grown for 48 hours in a custom medium (SCM-6; S5 Table), contain-
ing a total D-glucose concentration of 10 mM in a 1:1 ratio of D-glucose:13C-U-D-glucose
prior to LC-MS analysis. Labelling ratios of downstream metabolites were largely similar to
that of intracellular glucose, and carbon labelling patterns matched those that would be
expected in the BSF T. brucei glycolytic pathway (i.e. three 13C atoms in all metabolites down-
stream of glyceraldehyde 3-phosphate and glycerol-3-phosphate). Similar to T. brucei, a high
percentage of 3-carbon labelled fructose-1,6-bisphosphate (FBP) (34.8%) was observed in T.
congolense (Fig 3H), probably a result of the “reverse” aldolase reaction occurring in the glyco-
some [45]. Importantly, two-carbon labelling was observed in several acetylated compounds
(N-acetylornithine & N-acetyl-L-lysine; Fig 3H), confirming that acetyl groups used to gener-
ate these metabolites originate from D-glucose. Although acetyl-CoA, the product of pyruvate
oxidation, was not detected for technical reasons, the 2-carbon labelling patterns of acetylated
metabolites suggests that the acetyl moieties in these compounds originate from glucose,
potentially through acetyl-CoA and acetate, as previously evidenced in other trypanosomatids
[45,69]. Taken together, these data indicate that the flow of carbon atoms for glycolytic compo-
nents in T. congolense is very similar to that in T. brucei. However, the metabolic outputs differ
drastically from BSF T. brucei and appear to be more similar to PCF T. brucei.
Metabolite labelling was corrected for the 1:1 (50%) ratio of natural glucose to 13C-U-D-
glucose, which equated to a mean percentage labelling of 43.2% (the value is less than 50% due
to D-glucose in the serum). All glycolytic metabolites up to pyruvate showed>40% labelling
when corrected (for glucose 6-phosphate and fructose-1,6-bisphosphate, both 3-carbon and
6-carbon labels were taken into account), although glycerol and glycerol 3-phosphate exhibited
28.5% and 32.5% labelling, respectively, as these metabolites can also be obtained from catabo-
lism of lipid precursors. Moreover, 42.4% (49.1% corrected) labelling was detected in L-ala-
nine, suggesting that the alanine aminotransferase reaction that utilizes pyruvate to generate
2-oxoglutarate and L-alanine in both BSF and PCF T. brucei, also occurs in BSF T. congolense
[45,70]. For both malate and succinate, 3 carbons were derived from glucose and these metab-
olites showed 40.2% (46.6% corrected) and 32.3% (37.7% corrected) labelling, respectively.
These results suggest that glucose is not the only source of intracellular succinate and malate in
T. congolense. However, these values were higher than those reported in T. brucei (35% and
26% for malate and succinate, respectively [45]).
Whilst PCF T. brucei exhibit TCA cycle activity, this pathway is not used to catabolize glu-
cose [38,40]. No citric acid cycle intermediate isotopologues (e.g. citrate) were found when
BSF T. congolense were incubated with 13C-U-D-glucose, indicating that like in T. brucei, T.
congolense TCA metabolism is not linked to glycolysis. However, small amounts of 2-carbon
labelled succinate and malate were observed (Fig 3H), which can be explained by the reversal
of the glycosomal succinate shunt. Taken together, these data suggest that BSF T. congolense,
both from in vitro cultures and in vivo infection, metabolically resemble an intermediate
between BSF and PCF T. brucei, with moderate glycolytic capacity and significant levels of suc-
cinate shunt activity (glycosomal, rather than mitochondrial; S1 Table) as well as a highly
active mitochondrial acetate generating pathway.
Previous work has shown that reduction of glucose concentrations in BSF T. brucei culture
from 10 mM to 5 mM leads to decreased cellular motility, reduction in growth and cell body
rounding morphology within 8 hours [71]. Given that glucose was not substantially depleted
in T. congolense cultures after 56 h, we tested the effect of reduced glucose concentrations on
BSF T. congolense viability. Unlike T. brucei, T. congolense was able to maintain a growth rate
equal to controls at concentrations as low as 2 mM (Fig 4A) when continuously passaged with
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no observable change in morphology or motility. To test whether glucose-derived ATP was
essential to T. congolense, cells were incubated with D-glucose in addition to varying concen-
trations of 2-deoxy-D-glucose (2DG), which can be internalised, but not metabolised further
than 2-deoxy-D-glucose 6-phosphate. As a result, glycolysis and pentose phosphate pathway
metabolism are inhibited and glycosomal ATP levels are depleted as they cannot be regener-
ated in the latter stages of glycolysis, leading to a drastic change in glycosomal ATP/ADP ratio
[72] (Fig 4B). Incubation of T. congolense in medium supplemented with 2DG (in addition to
10 mM glucose) led to growth defects in a dose dependent manner, likely due to 2DG being
outcompeted by glucose at lower concentrations (Fig 4B). Although the growth defect was
minor in the presence of 1 mM 2DG, there was a more pronounced reduction with 5 mM
2DG. When equimolar concentrations of glucose and 2DG were used, growth was repressed
and cell death occurred within 48 hours (Fig 4B). T. congolense viability was also tested in
SCM-6 in the presence of N-acetyl-D-glucosamine (GlcNAc), a sugar that inhibits glucose
Fig 4. In vitro analysis of glycolytic metabolism. A) T. congolense remains viable in reduced glucose concentrations. A growth defect was only observed when glucose
concentrations were reduced to<2 mM. B) Supplementation with increased concentrations of 2-deoxy-D-glucose leads to T. congolense cell death (red dotted line
indicates detection limit by haemocytometer). C) Analysis of growth in the presence and absence of N-acetyl-D-glucosamine. Parasites were cultured in SCM-6
supplemented with 10 mM or 2 mM glucose in the presence or absence of 60 mM GlcNAc and density monitored by haemocytometer every 24 hours. D) Knock-down
of the entire glucose transporter (TcoHT) array does not affect in vitro cell viability. RNAi was induced in three independent clones by the addition of 1 μg/mL
tetracycline (Tet), and cell densities of induced and uninduced cells were monitored daily. E) Normalised TcoHT mRNA abundance over time after RNAi induction. F)
Changes in glucose uptake in RNAi-induced cells were detected via an enzyme-linked luminescence assay coupled to 2-deoxy-D-glucose uptake over a period of 30
minutes. The assay was carried out 72-hours post-induction. Of the three RNAi lines, 2 showed a significant reduction in glucose uptake capability (Student’s T-test,
�P< 0.05; ���P< 0.001).
https://doi.org/10.1371/journal.ppat.1009734.g004
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uptake [73] (Fig 4C). In the presence of 60 mM GlcNAc with 10 mM glucose, there was a mod-
erate, yet significant (p< 0.0001 at 96 h, t-test of cell densities) growth defect in T. congolense
(Fig 4C). Viability was further reduced when the same concentration of GlcNAc was used
alongside 2 mM glucose (p< 0.0001 at 96 h, t-test of cell densities), the lowest concentration
T. congolense could tolerate (Fig 4C). The rate of glucose consumption was measured by assay-
ing glucose concentrations in cell culture supplemented with 4 mM glucose. Doubling times
(6–7 hours and 11–12 hours for T. brucei and T. congolense, respectively) were taken into
account, and rate of glucose uptake was shown to be 47.17 ± 27.91 nmol-1 min-1 108 cells in T.
congolense, significantly lower than the rate (132.18 ± 16.31 nmol-1 min-1 108 cells) in T. brucei
(n = 4, p = 0.0039; t-test) which was comparable to previous studies [27,61].
To further probe the essentiality of glucose uptake in BSF T. congolense, RNAi was used to
knock down expression of the hexose transporter (TcoHT) array, specifically those matching
the THT1 and THT2 array in T. brucei (TcIL3000.A.H_000260500, TcIL3000.A.H_000260600,
TcIL3000.A.H_000794500, TcIL3000.A.H_000794600, TcIL3000.A.H_000794700), which has
been shown to significantly restrict growth of BSF T. brucei [74]. Whilst growth rate was unaf-
fected in BSF T. congolense (Fig 4D), induction of HT RNAi led to a reduction in transcript
abundance at all time points (mean transcript levels of 83%, 75%, 68% and 65% compared to
uninduced controls at 24, 48, 72 and 96 h post-induction, respectively; Fig 4E). Glucose uptake
was decreased (mean reduction of 37% in uptake compared to uninduced controls after 72 h;
Fig 4F), suggesting that either lower levels of glucose are sufficient for energy generation in T.
congolense, or the parasite can utilize other carbon sources for ATP production. These alterna-
tive sources could include medium or serum components such as amino acids [75].
PCF T. brucei express most components of the electron transport chain (ETC) to generate
ATP through oxidative phosphorylation. In contrast, BSF T. brucei express an F1Fo-ATPase
that functions in reverse, and alternative oxidase [76]. In addition, a recent study has suggested
that complex I is expressed and functional in BSF T. brucei [77]. Transcriptomics analysis of
the ETC was carried out, using a gene list generated by Zikova and colleagues [76], but no sig-
nificant patterns could be discerned, and thus we were not able to draw a conclusion with
regards to ETC activity in BSF T. congolense based on transcriptomics data alone (S1 Table
and S3 Fig).
Nucleotide metabolism
Metabolomic analysis of BSF T. congolense culture supernatants indicated a significant uptake
of exogenous ribose, a contributor to nucleotide metabolism via uptake, or via the pentose
phosphate pathway (PPP; Figs 2A and 5A). Whilst guanosine was not detected in the superna-
tant, significant accumulation of guanine (Fig 5B) was observed, suggesting either excretion of
this metabolite, or, hydrolysis of guanosine through parasite-secreted hydrolases/nucleosidases
(previously identified in BSF T. brucei secretomes [78,79]). This mechanism would enable
uptake of guanine and other nucleobases through nucleobase transporters, for which multiple
orthologues have been identified in the T. congolense genome [21] through homology with
known T. brucei nucleobase transporters TbNT8.1 and TbNBT1 [80,81]. In addition, there
was an accumulation of xanthine, a product of xanthosine hydrolysis, and depletion of inosine,
an important nucleoside composed of hypoxanthine and ribose (Fig 5C and 5D). The nucleo-
side cytidine and the nucleobase hypoxanthine were also detected, but appeared to remain
unchanged during the time course, although the latter was a medium supplement potentially
added in excess (S3 Table). It is noteworthy that only a single nucleoside transporter gene
(TbTc_1072; T. congolense gene IDs: TcIL3000.A.H_000665800 and the pseudogene
TcIL3000.A.H_000679300; S2 Table) can be identified in T. congolense, which is a syntenic
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Fig 5. Nucleotide metabolism in T. congolense. Supernatant analysis of T. congolense in vitro cultures showing changes in abundance of D-ribose (A), guanine (B),
xanthine (C) and inosine (D) over 56 hours. Grey bar indicates a negative medium control group E) Simplified overview of purine salvage and synthesis in
trypanosomatids (adapted from [148]). Numbers indicate the following enzymes: 1, APRT; 2, AD; 3, HGPRT; 4, IMPD; 5, HGXPRT; 6, GMPR; 7, GMPS; 8, HGPRT.
Red cross indicates guanine deaminase, which is not encoded/annotated in the T. congolense genome (based on current assembly). F) Comparison of glucose-derived
purine carbon labelling in T. congolense and T. brucei [45]. Colours indicate the number of 13C atoms in each metabolite. G) Comparative RNAseq analysis of T.
congolense and T. brucei under both in vitro and ex vivo conditions. Gene IDs from top to bottom: PWY0-162 (pyrimidine biosynthesis): PYR1A-B, glutamine
hydrolysing carbomoyl phosphate synthase, TbTc_1631; DHODH, dihydroorotate dehydrogenase (fumarate), TbTc_0620; CTPS, cytidine triphosphate synthase,
TbTc_0920; PYR3, dihydroorotase, TbTc_3801; PYR2, aspartate carbamoyltransferase, TbTc_1630; CMF40a, nucleoside diphosphate kinase, TbTc_5784; OMPDC/
OPRT, orotidine-5-monophosphate decarboxylase/orotate phosphoribosyltransferase, TbTc_0735. PWY0-163 (pyrimidine salvage): CMF40a, nucleoside diphosphate
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homologue of TbNT10 [21], functionally characterized as a P1-type purine nucleoside trans-
porter [82], and is thus unlikely to transport cytidine [83].
Purine salvage is an essential process in trypanosomatids, as they lack the de novo synthesis
pathway for the purine ring [84], and previous analysis of cell pellets to investigate intracellular
nucleotide metabolism utilizing 13C-U-D-glucose in BSF T. brucei showed purine salvage
pathways incorporating 5-carbon labelled ribose derived from glucose [45] (Fig 5F). Whilst
the ribose incorporated into these nucleosides originates almost exclusively from glucose in T.
brucei (Fig 5F), T. congolense appears to use far less glucose-derived ribose to make purine
nucleosides such as adenosine, guanosine and inosine (Fig 5F).
Transcriptomics analyses indicated upregulation of genes associated with generation of
adenosine nucleotides (Fig 5G; red vertical bar), especially in ex vivo T. congolense, as well as
hypoxanthine-guanine phosphoribosyltransferase (HGPRT) and uracil phosphoribosyltrans-
ferase (UPRT). Upregulation of nucleoside hydrolases and phosphoribosyltransferases sup-
ports a previous suggestion based on genome content that T. congolense has a capacity for
nucleobase uptake [21].
The purines guanosine and inosine, which incorporate glucose-derived ribose in T. brucei,
were almost entirely unlabelled in T. congolense (Fig 5F). However, the phosphorylated nucleo-
sides GMP, GDP and GTP all incorporate glucose-derived carbon atoms, presumably through
ribose. Given the labelling patterns seen in adenosine, one possible explanation could be con-
version of AMP to inosine monophosphate (IMP; adenosine monophosphate deaminase;
TbTc_0145), IMP to xanthosine monophosphate (IMP dehydrogenase; TbTc_1648) and XMP
to GMP (GMP synthase; TbTc_1452). However, only one of these enzymes, GMP synthase,
was expressed at higher abundance in T. congolense (log2 fold change: 1.61 and 2.06 for ex vivo
and in vitro, respectively; false discovery rate-adjusted p< 0.001). Overall, incorporation of
glucose-derived carbons into purine nucleosides is reduced in T. congolense compared to T.
brucei. It should be noted that in both experiments, there was no ribose supplementation in
the media
Of the pyrimidines, uracil and its derivatives were detected during the glucose labelling
experiment (S4 Fig). Uracil is known to be the main pyrimidine salvaged by other kinetoplas-
tids including T. brucei [85–87]. Whilst the majority of the uridine, UMP, UDP and UTP
pools incorporate glucose-derived ribose (five 13C labels), 5-carbon isotopologues of these
pyrimidines were reduced in abundance in T. congolense compared to T. brucei. Conversely,
2-carbon labelled isotopologues appeared to comprise the majority of uridine, uracil and their
nucleotides (S4 Fig).
Whilst uracil biosynthesis is not essential in T. brucei [88], the uracil pool in T. congolense
appears to derive almost entirely from glucose, when corrected for 50% glucose labelling
(45.9% in T. congolense vs 24% in T. brucei [45]; S4 Fig), suggesting that this species predomi-
nantly synthesizes uracil from orotate to UMP (orotate phosphoribosyltransferase/orotidine
5-phosphate decarboxylase; TbTc_0735) and from UMP to uracil (uracil phosphoribosyltrans-
ferase; TbTc_4220), as can occur in T. brucei [45]. Both these genes are expressed at higher
abundance in T. congolense, both in vitro and ex vivo, compared to T. brucei (Fig 5G and S1
Table), which could explain the increased isotopologue labelling.
kinase, TbTc_5784; NDPK3, nucleoside diphosphate kinase 3, TbTc_2560; NDPK, nucleoside diphosphate kinase, TbTc_0593; CDA, cytidine deaminase, TbTc_3318;
UPRT, uracil phosphoribosyltransferase, TbTc_4220; UP, uridine phosphorylase, TbTc_5794. P121-PWY (adenine/adenosine salvage): ADSL, adenylosuccinate lyase,
TbTc_1986; APRT-2, glycosomal adenine phosphoribosyltransferase, TbTc_5918; GMPR, GMP reductase, TbTc_4627; IMPDH1, inosine-5’-monophosphate
dehydrogenase, TbTc_1648; HGXPRT, hypoxanthine-guanine-xanthine phosphoribosyltransferase, TbTc_3696; APRT-1, cytosolic adenine phosphoribosyltransferase,
TbTc_3522; HGPRT, hypoxanthine-guanine phosphoribosyltransferase, TbTc_0726; ADSS, adenylosuccinate synthetase, TbTc_1142.
https://doi.org/10.1371/journal.ppat.1009734.g005
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These data indicate that, at least under the growth conditions used here, BSF T. congolense
favours purine nucleoside/nucleotide synthesis from nucleobases with a reduced dependence
on glucose-derived ribose 5-phosphate, in addition to de novo synthesis of orotate, uracil and
uridine nucleosides. However, the difference in serum requirements for the two organisms is a
confounding factor to the interpretation of this difference.
Amino acid metabolism
It is well established that trypanosomatid parasites scavenge amino acids, key nutrients for sur-
vival, from their hosts [89,90]. Therefore, comparative analyses of T. congolense and T. brucei
amino acid metabolism were undertaken. Whilst the majority of amino acids were detected
during the supernatant time course, relative abundances in the medium did not vary greatly
after 56 hours of in vitro culture (Fig 6A–6C and S3 Table). The greatest reductions were
observed in threonine (log2 FC after 56 hours: -0.89; Fig 6A), tryptophan (log2 FC: -0.74; Fig
6B), glutamine (log2 FC: -0.39), asparagine (log2 FC: -0.35) and phenylalanine (log2 FC: -0.35).
Interestingly, cysteine, an essential factor for the in vitro culture of T. brucei [63,91], was not
significantly consumed by 56 hours (log2 FC: -0.07; Fig 6C). However, at least low-level exoge-
nous cysteine is still required to sustain parasite growth in vitro, as viability was significantly
affected in the absence of cysteine (for both 1.5 mM and 1 mM vs 0 mM cysteine, p< 0.0001,
t-test of cells densities at 96 h; S5 Fig). Experiments were carried out to test the essentiality of
all other individual amino acids (with the exception of glutamine, known to be an important
amino donor in trypanosomatid metabolism [60,89]). Using the minimal medium SCM-6, cell
viability was monitored for 72 hours in the absence of specific amino acids. Removal of the fol-
lowing amino acids from culture medium led to defects in growth over 72 hours: asparagine,
histidine, isoleucine, leucine, methionine, proline, serine, tyrosine and valine (Fig 6D–6G).
Whilst aspartate appeared to be depleted in spent culture supernatants (S3 Table), this also
occurred in the medium only control. Furthermore, removal of aspartate did not lead to
reduced cell viability or growth rate in culture (Fig 6F). Long term culture was impossible
without the addition of phenylalanine and threonine, leading to a final culture formulation,
SCM-7 (S5 Table), containing a total of 14 amino acids. Therefore, BSF T. congolense appears
to require a higher number of amino acids than BSF T. brucei, at least in vitro, with CMM con-
taining only 8 amino acids in total, including cysteine and glutamine [60]. To further probe
amino acid metabolism, pathway analysis was carried out on the transcriptome (S6 Fig) and
metabolome (Figs 6 and S7 and S8).
BSF T. brucei utilizes exogenous L-glutamine as the primary source of intracellular gluta-
mate and 2-oxoglutarate, and produces significant levels of glutamine-derived succinate
[45,89] (Fig 6I). Given the high levels of succinate excreted by T. congolense, stable isotope
labelling was used to determine the contribution of L-glutamine to this pool. T. congolense was
incubated for 48 hours with 1 mM 13C-U-L-glutamine and cell pellets were analysed by
LC-MS. Results indicated the presence of biochemical activities consistent with those previ-
ously observed in T. brucei [89] (Fig 6). Significant glutamine-derived carbon labelling was
detected after 48 h incubation for succinate (41.3%, 48.5% corrected), glutamate (76.1%, 89.2%
corrected), 2-oxoglutarate (80.5%, 94.3% corrected) and succinate semialdehyde (94.7% cor-
rected, Fig 6I). As would be anticipated, labelling of glutathione (86.1%) and trypanothione
(98.4%) from glutamine through glutamate was also observed (S7 Fig). No labelling of malate
or aspartate was seen in this study, despite the use of high concentrations of 13C-U-L-gluta-
mine compared to the equivalent study performed in T. brucei with a 50:50 ratio of 13C-U-L-
glutamine [89]. Transcriptomics analysis showed high expression levels of glutamine synthe-
tase in T. congolense, compared to T. brucei, under ex vivo conditions only, suggesting ATP-
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Fig 6. Amino acid metabolism in T. congolense IL3000. A-C) Analysis of indicated amino acids in T. congolense IL3000 culture supernatants over a
56 h time course. Grey bars indicate a negative medium control group. D-F) Growth curves in SCM-6 excluding one amino acid at a time, to
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dependent generation of glutamine may occur in the parasite under these conditions (S1
Table).
The apparent essentiality of several amino acids was also investigated using stable isotope
labelling. Proline is an essential carbon source for PCF T. brucei and is required for protein
synthesis in BSF T. brucei, although it is not a required supplement in BSF medium [92]. In
contrast, removal of proline from BSF T. congolense medium led to reduced growth (Fig 6F).
RNAi-mediated knock-down of proline metabolism (specifically pyrroline-5-carboxylate
dehydrogenase, TbP5CDH) in PCF T. brucei has highlighted the requirement of proline
metabolism for mitochondrial function [92]. Indeed, both P5CDH (TbTc_1695) and proline
dehydrogenase (TbTc_1591) were expressed at higher levels in ex vivo T. congolense, compared
to T. brucei (S1 Table and S6 Fig). However, 13C-U-L-proline labelling showed that this amino
acid did not contribute meaningfully to the biosynthesis of other metabolites (S8 Fig). There-
fore, similar to BSF T. brucei, a requirement for proline in BSF T. congolense may be for the
purposes of polypeptide synthesis only.
As in T. brucei [45], glucose-derived carbon usage was detected in several amino acids in T.
congolense (S6A Fig). Aspartate (a precursor for pyrimidine nucleotide biosynthesis) and ala-
nine (a by-product of a pyruvate-utilising aminotransferase reaction) (S6A Fig) exhibited
3-carbon isotopologues derived from 13C-U-D-glucose in both species. However, in T. brucei,
a small proportion of L-asparagine labelling was observed (1.2% 3-carbon labelling) [45],
whilst none was observed in T. congolense (S6A Fig). The metabolism of asparagine has not
been studied in African trypanosomes; given the reduction of cell growth in the absence of this
amino acid (Fig 6F), labelling with 13C-U-L-asparagine was performed, but no other labelled
metabolites were detected (S8 Fig). This indicates that, as with proline, asparagine uptake is
required principally for protein synthesis in T. congolense. The reduced expression of aspara-
gine synthetase (TbTc_4894; TcIL3000.A.H_000497800), which converts aspartate to aspara-
gine (S6 Fig), suggests that BSF T. congolense may rely upon scavenging of exogenous
asparagine.
Serine was also shown to be essential to T. congolense (Fig 6F), in contrast to minimal cul-
turing requirements for T. brucei [60]. 13C-U-L-serine labelling indicated that T. congolense L-
serine metabolism mirrors that of T. brucei in several aspects, such as de novo sphingolipid bio-
synthesis, with 70.0% 2-carbon labelling of sphinganine and downstream labelling of ceramide
and sphingomyelin species (S8 Fig). Similarly, phosphatidylserine decarboxylase activity was
evidenced at both transcript and metabolite levels, with 40.1% 2-carbon labelling of glycerol-
phospho-ethanolamine (S1 Table and S8 Fig). However, L-serine also has a minor role in S-
adenosyl-L-homocysteine detoxification in T. congolense, where serine-derived carbon ulti-
mately contributes to cysteine biosynthesis (S8 Fig). Serine-derived carbon labelling was
detected in cystathionine (18.1%) and cysteine (16.7%), through to glutathione (4.1%) and try-
panothione disulfide (3-carbon labelled, 6.8%; 6-carbon labelled, 0.02%; S7 Fig). Therefore, the
inability to exclude L-serine from T. congolense in vitro culture media may primarily be attrib-
utable to lipid metabolism and an increased demand for serine-derived cysteine, potentially
over exogenously obtained cysteine, depending on bioavailability. Indeed, metabolomics
determine those essential to T. congolense viability. In each experiment, full SCM-6 was used as a positive control. Legends indicate which amino acid
was removed in each experiment. G) Growth analysis of SCM-6 and SCM-7, the latter containing only amino acids deemed essential, compared to
HMI-93 [124]. H) Simplified map of intracellular glutamine metabolism. Numbers refer to the following enzymes: 1, glutaminase; 2, glutamate
decarboxylase; 3, 4-aminobutyrate aminotransferase; 4, succinate semialdehyde dehydrogenase; 5, glutamate dehydrogenase; 6, 2-oxoglutarate
dehydrogenase; 7, Succinyl-CoA synthetase; 8, isocitrate dehydrogenase; 9 & 10, aconitase. I) Carbon utilisation from L-glutamine was analysed in T.
congolense (100% 13C-U-L-glutamine) and compared to that in T. brucei (50:50 ratio of L-glutamine and 13C-U-L-glutamine) [89].
https://doi.org/10.1371/journal.ppat.1009734.g006
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analysis of culture medium indicates that the ability of T. congolense to take up cysteine from
its environment may be lower than in T. brucei (Fig 6C).
Although L-cysteine is primarily considered a source of sulphur for trypanosomatids
[89,91,93], we also investigated the carbon contribution of this amino acid in T. congolense,
and in particular, whether L-cysteine-derived carbon atoms contribute to the biosynthesis of
glutathione and trypanothione. 13C-U-L-cysteine stable isotope labelling experiments were
performed (S7 and S8 Figs). Direct replacement of the 1.5 mM L-cysteine present in SCM-6
with 13C-U-L-cysteine led to high levels of labelling in glutathione and trypanothione disulfide
(S7B Fig). This indicates that T. congolense can readily take up and metabolise exogenous cys-
teine, even though abundance of the amino acid is not reduced significantly over 56 hours of
parasite in vitro culture. Although no clear pattern could be observed in transcriptomic analy-
sis of the trypanothione biosynthesis pathway, both trypanothione synthase (TRYS;
TbTc_1359) and trypanothione reductase (TRYR; TbTc_4239) were expressed at high levels in
in vitro T. congolense cells relative to ex vivo cells, indicating that under in vitro conditions,
cells may be subjected to higher levels of oxidative stress (S7C Fig).
There were several further notable observations in the transcriptomics data regarding
deamination and decarboxylation of amino acids. For example, cytosolic aspartate amino-
transferase (cASAT; TbTc_0799) was expressed at similar levels in both species, indicating that
the transamination of tryptophan, tyrosine and phenylalanine to generate aromatic ketoacids
[94,95] likely occurs in T. congolense. The mitochondrial isoform (mASAT; TbTc_0877) was
expressed at higher levels in cultured T. congolense (log2 FC: 1.73, p< 0.001), indicative of
increased mitochondrial amino acid metabolism.
Fatty acid metabolism in T. congolense
Lipids have a variety of crucial roles in trypanosomes, in particular as a major constituent of
membranes. BSF T. brucei require large quantities of myristic acid in particular, for the synthe-
sis of glycosylphosphatidylinositol (GPI) that anchors the parasite’s major surface glycopro-
teins [96]. To do this, BSF T. brucei both synthesises and scavenges myristic acid. Glucose
labelling experiments in T. brucei have shown that myristic acid is partially synthesized from
glucose-derived carbon through acetyl-CoA, using a system of fatty acid elongases [97] (Fig
7A). One previous study suggested that GPI anchors in T. congolense also incorporate myristic
acid [98]. However, no saturated fatty acid carbon labelling was detected after incubation of T.
congolense with 13C-U-D-glucose (Fig 7A), unlike T. brucei [45]. Carbon dissemination was
also investigated from threonine, which is used as a source of acetate, and thus, lipids [99] (Fig
7B). Similarly, no saturated lipid carbon labelling was observed, suggesting that T. congolense
either uses alternative sources of carbon for lipid biosynthesis, or does not rely on acetate as a
source of lipids in the same way as T. brucei [33].
Several genes associated with acetate/acetyl-CoA metabolism were highly expressed in T.
congolense compared to T. brucei (Fig 7C). For example, ASCT (TbTc_0236), which catalyses
ATP-coupled acetate production, was higher under both conditions in T. congolense (log2 fold
changes: 2.04 and 0.46 for in vitro and ex vivo, respectively, p< 0.001; S1 Table). Conversely,
acetyl-CoA hydrolase (also known as acetyl-CoA thioesterase, ACH; TbTc_5515), an enzyme
involved in ATP synthesis-uncoupled acetate production in T. brucei [100] was expressed at
lower levels in ex vivo T. congolense compared to T. brucei (Fig 7C). Consistent with metabolic
data, expression of acetyl-CoA synthetase (AceCS; TbTc_0318), a key enzyme in lipid biosyn-
thesis from acetate, was reduced in both ex vivo and in vitro T. congolense (Fig 7C). Other
enzymes involved in fatty acid biosynthesis, namely acetyl-CoA carboxylase (ACC;
TbTc_0754), β-ketoacyl-CoA synthase (BKS; TbTc_3372) and β-ketoacyl-CoA reductase
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Fig 7. Fatty acid metabolism in T. congolense. A) Glucose-derived 13C carbon labelling of saturated fatty acids in T. congolense and T. brucei [45]. Colours correspond
to the number of 13C labels detected in each metabolite. B) L-threonine-derived saturated fatty acid 13C labelling in T. congolense. Fatty acid systematic names and
numbers: lauric acid: dodecanoic acid, C12:0; myristic acid: tetradecanoic acid, C14:0; palmitic acid: hexadecanoic acid, C16:0; nonadecyclic acid: nonadecanoic acid,
C19:0. C) Transcriptomics analysis of acetate and lipid metabolism. Gene names and IDs: Acetate metabolism (PWY1V8-8): AKCT, 2-amino-3-ketobutyrate-CoA
ligase, TbTc_6236; TDH, L-threonine 3-dehydrogenase, TbTc_5991; AceCS, acetyl-CoA synthetase, TbTc_0318; PYK1, pyruvate kinase, TbTc_0372; PDHe3, pyruvate
dehydrogenase E3, TbTc_4765; PDHe1β, pyruvate dehydrogenase E1 β subunit, TbTc_5437; PPDK, pyruvate phosphate dikinase, TbTc_1304; SCSα, succinyl-CoA
synthetase α subunit, TbTc_0813; PDHe1α, pyruvate dehydrogenase E1 α subunit, TbTc_4169; ACH, acetyl-CoA hydrolase/thioesterase, TbTc_5515; PDHe2,
dihydrolipoamide acetyltransferase, TbTc_1015. Fatty acid biosynthesis (PWY0-881): ACC, acetyl-CoA carboxylase, TbTc_0754; BKS, β-ketoacyl synthase, TbTc_3372;
BKR, β-ketoacyl-ACP reductase, TbTc_1241. Sterol metabolism (PWY1V8-3): SPPS, solanesyl-diphosphate synthase, TbTc_3025; SQase, squalene synthase,
TbTc_2577; CYP51A1, lanosterol 14α demethylase, TbTc_4837; SMT, sterol 24-c methyltransferase, TbTc_0387; LSS, lanosteral synthase, TbTc_4540; MVK,
mevalonate kinase, TbTc_3761; FPPS, farnesyl pyrophosphate synthase, TbTc_5375; HMGCL, hydroxymethylglutaryl-CoA lyase, TbTc_6160; SM, squalene
monooxygenase, TbTc_3357; MDD, mevalonate diphosphate decarboxylase, TbTc_0546; IDI, isopentenyl-diphosphate delta-isomerase, TbTc_1099; PTase,
prenyltransferase, TbTc_1352; GGTase-IIβ, geranylgeranyl transferase type II β subunit, TbTc_0680; SCP2, 3-ketoacyl-CoA thiolase, TbTc_4024; PMVK,
phosphomevalonate kinase, TbTc_3039; HMGR, 3-hydroxy-3-methylglutaryl-CoA reductase, TbTc_3189. Fatty acid oxidation (FAO-PWY): ECH, enoyl-CoA
hydratase, TbTc_3283; ACS3/ACS4, fatty acyl-CoA synthetase 3 & 4, TbTc_0101; ACS2, fatty acyl-CoA synthetase 2, TbTc_0102; LACS5, fatty acyl-CoA synthetase,
TbTc_0099; ACSL_0688, long-chain-fatty-acid-CoA ligase, TbTc_0688; ACSL_2381, long-chain-fatty-acid-CoA ligase, TbTc_2381; ACS1, fatty acyl-CoA synthetase 1,
TbTc_0100; TFEα1, enoyl-CoA hydratase/enoyl-CoA isomerase, TbTc_3362; ECI_4184, 3,2-trans-enoyl-CoA isomerase, TbTc_4184; SCP2, 3-ketoacyl-CoA thiolase,
TbTc_4024; ECI_0360, 3,2-trans-enoyl-CoA isomerase, TbTc_0360; ACAD, acyl-CoA dehydrogenase, TbTc_4954.
https://doi.org/10.1371/journal.ppat.1009734.g007
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(BKR; TbTc_1241), were all expressed at lower abundance in T. congolense than T. brucei, in
particular in ex vivo cells (Fig 7C). Of the four elongases, ELO1 (TbTc_0159) and ELO2
(TbTc_1882) were expressed at similar levels in both BSF T. congolense and T. brucei (S1
Table). Whilst expression of ELO3 (TbTc_0235) appeared to be reduced in T. congolense (log2
FC: -1.53 and -1.93 compared to T. brucei for in vitro and ex vivo, respectively, p< 0.001; S1
Table), T. congolense cells expressed higher levels of ELO4 (TbTc_0737) in both in vitro and ex
vivo conditions, compared to T. brucei (log2 FC: 1.43 and 1.44 for in vitro and ex vivo compari-
sons, respectively, p< 0.001).
Lipoic acid, a fatty acid de novo synthesised by kinetoplastids [97,101], was not detected
using the LC-MS platform. However, gene expression data indicated that transcript abundance
of genes involved in lipoic acid synthesis (lipoic acid synthase, TbTc_4472; dihydrolipodamide
dehydrogenase, TbTc_0275 and TbTc_0276) was similar across both species (p = 0.115), sug-
gesting T. congolense also synthesise lipoic acid de novo.
The variation in observed gene expression associated with the sterol pathway appeared to
correlate with sample condition rather than species (Fig 7C). However, T. congolense tran-
scripts for genes involved in lanosterol synthesis were reduced, especially under in vitro condi-
tions (squalene synthase, SQase, TbTc_2577; squalene monooxygenase, SM, TbTc_3357;
lanosterol synthase, LSS, TbTc_4540; Fig 7C).
Transcripts associated with fatty acid oxidation were less abundant in T. congolense com-
pared to T. brucei under both conditions (Fig 7C). Energy generation from fatty acids has not
been reported for T. brucei. In T. congolense, high abundance of transcripts in key genes such
as enoyl-CoA hydratase (ECH; TbTc_3283), particularly in ex vivo samples, was observed. It
would therefore be important to establish whether this species has a capacity for fatty acid
oxidation.
Exploiting differences in metabolism for potential pharmacological
intervention
Differences in metabolism between T. congolense and T. brucei have implications for differen-
tial drug efficacy between the two species. To validate our findings in key areas of metabolism,
pharmacological inhibition was attempted for specific targets in trypanosome metabolism, in
order to compare inhibitory concentrations (EC50).
To assess whether areas of mitochondrial metabolism were more necessary in BSF T. congo-
lense than in BSF T. brucei, both species were treated with FCCP, an uncoupling agent that
depolarises the mitochondrial membrane. However, there was no difference in sensitivity
between the species (EC50: 13.0 ± 5.0 μM and 12.6 ± 5.3 μM for T. brucei and T congolense,
respectively; Table 1). Given both metabolic and transcriptomic data indicated no increased
electron transport chain activity, we also treated with the complex III inhibitor antimycin A,
again with no significant differences observed between the species (Table 1). In addition, there
was no change in sensitivity to azide, an inhibitor of ATP hydrolysis by the F1-ATPase
(Table 1). However, T. congolense appeared to be less sensitive to rotenone, a complex I
NADH dehydrogenase inhibitor (Table 1). Previous data inferred complex I activity in BSF T.
congolense based on nitroblue tetrazolium staining [51]. Rotenone resistance could indicate
NADH dehydrogenase activity of a rotenone-insensitive NADH dehydrogenase, such as the
inner membrane space-facing NDH2 [77].
T. congolense also showed enhanced sensitivity to salicylhydroxamic acid (SHAM), an
inhibitor of the trypanosome alternative oxidase (TAO; Table 1) [102]. Sensitivity of both spe-
cies to SHAM was also tested in the presence of 10 mM glycerol (Table 1). Addition of glycerol
as a carbon source has previously been shown to increase T. brucei sensitivity to SHAM [103].
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Both species exhibited increased sensitivity to SHAM in the presence of glycerol (EC50 of
2.28 ± 3.0 μM and 5.00 ± 0.1 μM for T. congolense and T. brucei, respectively). This represented
a 12.1- and 13.3-fold increase in sensitivity for T. congolense and T. brucei, respectively. Taken
together, these data indicate that, like T. brucei, T. congolense does not rely on oxidative phos-
phorylation for ATP production, as indicated by transcriptomics analysis, and that, as previ-
ously reported, TAO is the terminal oxidase [51,54].
Metabolomics and transcriptomics data indicated that T. congolense direct pyruvate
towards mitochondrial metabolism, with high transcript levels in PDH and enzymes involved
in acetate generation, compared to T. brucei (Figs 3 and 7). We therefore hypothesised that T.
congolense would be more sensitive to inhibition of mitochondrial pyruvate uptake, and to
investigate this further, we tested drug sensitivities for UK5099, an inhibitor of mitochondrial
pyruvate transport [104]. As expected, T. congolense (EC50: 82.1 μM) was significantly more
sensitive (p = 0.0091, unpaired t-test) to UK5099 compared to T. brucei (130.0 μM; Table 1).
Whilst acetate generation appears to be important in T. congolense, our data suggest that
the acetate does not appear to be utilised for the biosynthesis of fatty acids, in contrast to what
has been shown for T. brucei. To probe this further, we compared drug sensitivity of the two
species with compounds targeting fatty acid synthesis (S9 Fig). Indeed, T. congolense was sig-
nificantly more resistant than T. brucei to an acetyl-CoA synthetase inhibitor (AceCS inhibitor;
1-(2,3-di(thiophen-2-yl)quinoxalin-6-yl)-3-(2-methoxyethyl)urea, [105]; S9 Fig and Table 1),
indicating that AceCS is not as essential to this species. AceCS is essential to both BSF and PCF
T. brucei [33,69], thus indicating a key metabolic difference between the species.
We next compared drug sensitivity to Orlistat, an inhibitor of fatty acid synthase and phos-
pholipase [35]. Here, a striking difference was found, with T. congolense exhibiting signifi-
cantly less sensitivity (780-fold increase in EC50) to the compound compared to T. brucei (S9
Fig and Table 1), providing further evidence that T. congolense primarily relies on fatty acid
scavenging, instead of synthesis, as predicted by the combination of metabolomics and
transcriptomics.
Discussion
The protozoan parasite T. congolense is a principal cause of AAT, but crucially, T. brucei
remains the dominant model for laboratory-led studies of African trypanosomes, even in the
face of mounting evidence that T. brucei and T. congolense differ profoundly in many facets of
their biology. This study aimed to generate a detailed comparison of metabolism in T.
Table 1. Comparative analysis of sensitivity to metabolic inhibitors in T. congolense and T. brucei. Abbreviations: FCCP, carbonyl cyanide-p-trifluoromethoxyphenyl-
hydrazone; SHAM, salicylhydroxamic acid; TAO, trypanosome alternative oxidase; AceCS, acetyl-CoA synthetase.
Compound Target T. congolense EC50 Mean ± SEM T. brucei EC50 Mean ± SEM Fold change (Tc/Tb) P value (t-test)
Antimycin Complex III 271.2 ± 143.5 μM 144.2 ± 18.1 μM 1.9 0.4295
FCCP Uncoupling agent 12.6 ± 5.3 μM 13.0 ± 5.0 μM 1.0 0.9592
Azide Complex V (F1-ATPase) 432.3 ± 127.9 μM 235.0 ± 6.0 μM 1.8 0.1982
Oligomycin Complex V (F0-ATPase) 33.9 ± 14.1 nM 197.6 ± 39.0 nM 0.2 0.0169
Rotenone Complex I 27.4 ± 1.4 μM 7.4 ± 0.9 μM 3.7 0.0003
SHAM TAO 30.22 ± 0.7 μM 60.23 ± 1.8 μM 2.0 0.0001
SHAM + 10 mM glycerol TAO 2.28 ± 3.0 μM 5.00 ± 0.1 μM 2.2 0.0008
UK5099 Pyruvate transport 82.1 ± 8.8 μM 130.0 ± 5.0 μM 0.6 0.0091
AceCS inhibitor Acetyl-CoA synthetase 57.7 ± 15.2 μM 7.1 ± 2.4 μM 8.1 0.0304
Orlistat Fatty acid synthase/lipases 15.6 ± 2.5 μM 0.02 ± 0.01 μM 780.0 0.0033
Diminazene Kinetoplast 50.0 ± 5.6 nM 32.0 ± 0.5 nM 1.6 0.0425
https://doi.org/10.1371/journal.ppat.1009734.t001
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congolense and T. brucei, through a combination of metabolomics, transcriptomics and gene
knockdown approaches. Based on these comparisons, areas of metabolism were further
probed with chemical inhibition, in order to validate findings.
Transcriptomic data were generated from T. congolense and T. brucei with parasite samples
isolated from both in vitro culture and in vivo murine infections (ex vivo). There were high lev-
els of correlation between ex vivo and in vitro T. congolense samples, indicating that the cul-
tured form of the parasite closely resembles the in vivo situation, at a transcriptomic level. In
contrast, there was lower inter-species correlation between T. brucei and T. congolense.
To complement the transcriptomic data, several metabolomic analyses were carried out to
gain an understanding of specific areas of metabolism. These data demonstrated that BSF T.
congolense, while possessing some metabolic similarities with BSF T. brucei, differs substan-
tially in several core components, including having a reduced reliance on glucose, excretion of
distinct glycolytic end products (acetate, malate and succinate in T. congolense compared to
pyruvate in T. brucei), and increased gene expression and metabolic signatures of specific
mitochondrial pathways, in particular pyruvate to acetate conversion. Additionally, we have
shown that T. congolense has increased reliance on exogenous substrates such as ribose for
nucleotide synthesis, as demonstrated by reduced glucose-derived carbon labelling in nucleo-
side species in addition to upregulation of hydrolases and phosphoribosyltransferases. Further-
more, while there is overlap in amino acid utilisation (e.g. glutamine), T. congolense relies on
more exogenous amino acids than T. brucei. Surprisingly, this included serine which, in the
case of T. congolense, appears to be important in the transsulfuration pathway that is geared
towards trypanothione biosynthesis. This may also explain the observed decreased reliance on
exogenous cysteine. Unlike T. brucei, T. congolense also requires asparagine and proline for
viable in vitro culture, although carbon usage from these amino acids is minimal. Finally, T.
congolense exhibits increased acetate/acetyl-CoA metabolism compared to T. brucei, despite a
reduction in fatty acid biosynthesis through the classical trypanosomatid pathways involving
acetyl-CoA synthase, acetyl-CoA carboxylase, β-ketoacyl-CoA synthase and β-ketoacyl-CoA
reductase, the expression of which are reduced in T. congolense (both in ex vivo and in vitro
conditions). This is further underlined by lack of glucose- and threonine-derived carbon label-
ling of saturated fatty acids, most notably myristic acid, a key GPI anchor component of vari-
ant surface glycoproteins of T. brucei and T. congolense [98]. However, fatty acid elongase 4,
previously shown to extend exogenously scavenged arachidonic acid (C22:4) to docosatetrae-
noic acid (C22:5) [106], was expressed at higher levels under in vitro conditions, compared to
T. brucei, which may indicate a reliance on long-chain polyunsaturated fatty acids. These find-
ings are summarised in Fig 8.
Analyses of culture supernatants showed that 10 mM glucose was not substantially depleted
after T. congolense cultures reached high cell density, as would be expected from an equiva-
lently dense T. brucei culture [60]. T. brucei requires at least 5 mM glucose in culture [71],
whereas BSF T. congolense were viable and maintained doubling times in levels as low as 2
mM. This reduced flux indicates that T. congolense is unlikely to be as susceptible to glycolytic
inhibition as T. brucei, where 50% inhibition is sufficient to kill the parasite [27]. Interestingly,
we observed a reproducible reduction in pyruvate levels in T. congolense supernatants over
time, before abundance of this metabolite returned to levels similar to those observed in nega-
tive controls. A recent study in PCF T. brucei demonstrated that these parasites can re-metabo-
lize glycolytic end products such as pyruvate and succinate [40]. Stable isotope labelling
patterns in catabolic products derived from glucose do not support cyclical TCA activity, nor
re-uptake of excreted metabolites in BSF T. congolense. However, it would be of interest to
determine whether this species can recycle the aforementioned metabolites.
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Fig 8. Summary of T. congolense and T. brucei in vitro transcriptome. Log2 fold change (T. congolense/T.brucei) was calculated for each gene. Dashed lines represent
transport processes. Genes: 1, hexose transporters, TbTc_0095; 2, hexokinase, TbTc_0341; 3, glucose-6-phosphate isomerase, TbTc_1840; 4, phosphofructokinase,
TbTc_1399; 5, fructose-1,6-bisphosphatase, TbTc_1967; 6, aldolase, TbTc_0358; 7, triosephosphate isomerase, TbTc_1075; 8, glycerol-3-phosphate dehydrogenase,
TbTc_2722; 9, glycerol kinase, TbTc_0392; 10, glyceraldehyde 3-phosphate dehydrogenase, TbTc_0377; 11, phosphoglycerate kinase, TbTc_0240; 12, phosphoglycerate
mutase, TbTc_5039; 13, enolase, TbTc_0465; 14, pyruvate kinase 1, TbTc_0372; 15, alanine aminotransferase, TbTc_0675; 16, pyruvate phosphate dikinase, TbTc_1304;
17, Phosphoenolpyruvate carboxykinase, TbTc_0348; 18, glycosomal malate dehydrogenase, TbTc_0642; 19, glycosomal fumarate hydratase, TbTc_0242; 20, glycosomal
NADH-dependent fumarate reductase, TbTc_0140; 21, glucose-6-phosphate dehydrogenase, TbTc_0931; 22, 6-phosphogluconolactonase, TbTc_4165; 23,
6-phosphogluconate dehydrogenase, TbTc_2025; 24, ribulose-5-phosphate epimerase, TbTc_4356; 25, ribose 5-phosphate isomerase, TbTc_3090; 26, transketolase,
TbTc_1701; 27, transaldolase, TbTc_1823; 28, ribokinase, TbTc_5212; 29, malic enzyme, TbTc_0296; 30, Mitochondrial pyruvate carrier 2, TbTc_2668; 31, FAD-
dependent glycerol-3-phosphate dehydrogenase, TbTc_2282; 32, NADH dehydrogenase (NDH2), TbTc_5033; 33, Alternative oxidase, TbTc_6589; 34, mitochondrial
fumarate hydratase, TbTc_0243; 35, mitochondrial NADH-dependent fumarate reductase, TbTc_0141; 36, mitochondrial malate dehydrogenase, TbTc_0256; 37, citrate
synthase, TbTc_0486; 38, aconitase, TbTc_5765; 39, isocitrate dehydrogenase, TbTc_0510; 40, 2-oxoglutarate dehydrogenase E1 component, TbTc_2864; 41,
2-oxoglutarate dehydrogenase E1 component, TbTc_3111; 42, 2-oxoglutarate dehydrogenase E2 component, TbTc_3057; 43, succinyl-CoA synthetase α, TbTc_0813; 44,
succinyl-CoA ligase β, TbTc_3392; 45, glutamine synthetase, TbTc_2226; 46, glutamate dehydrogenase, TbTc_0872; 47, pyruvate dehydrogenase E1 α subunit, TbTc_4169;
48, pyruvate dehydrogenase E1 β subunit, TbTc_5437; 49, dihydrolipoamide acetyltransferase, TbTc_1015; 50, pyruvate dehydrogenase complex E3, TbTc_4765; 51, L-
threonine 3-dehydrogenase, TbTc_5991; 52, 2-amino-3-ketobutyrate coenzyme A ligase, TbTc_6236; 53, Acetyl-CoA hydrolase (ACH), TbTc_5515; 54, Succinyl-
CoA:3-ketoacid coenzyme A transferase (ASCT), TbTc_0236; 55, Acyl carrier protein, TbTc_5262; 56, beta-ketoacyl-ACP synthase, TbTc_3372; 57, beta-ketoacyl-ACP
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T. congolense exhibits high levels of expression of genes in the glycosomal succinate shunt,
with the exception of fumarate reductase, the last step of succinate production, for reasons we
could not identify (Fig 8). In T. brucei these phenotypes are associated with PCF rather than
BSF. Furthermore, whilst the major PGK isoform in BSF T. brucei is expressed in the glyco-
some, a previous study suggested that the major isoform of phosphoglycerate kinase in BSF T.
congolense lacks the glycosomal targeting signal present in T. brucei, and is thus expressed in
the cytosol, akin to PCF T. brucei [49]. This has significant implications for glycosomal ADP/
ATP balance, as the expression of cytosolic PGK in BSF T. brucei is lethal [42]. Taken together,
these data suggest that T. congolense appears to carry out glycolytic metabolism in the same
fashion as PCF, not BSF T. brucei, including in ex vivo cells.
Whilst both 2-deoxy-D-glucose and GlcNAc have a detrimental impact on T. congolense
viability, knock-down of the glucose transporter array did not affect growth, even though glu-
cose uptake was reduced by 37% after 72 h of RNAi induction. Consistent with other studies
RNAi penetrance does not appear as efficient as in T. brucei [107] and techniques such as
CRISPR/Cas9 and conditional knock-out would greatly enhance our capabilities to study this
parasite. Nevertheless, these experiments highlight a crucial difference between BSF T. congo-
lense and T. brucei in a pathway that has become a metabolic paradigm in the latter species.
Whilst T. brucei requires high levels of glucose to sustain a significant glycolytic flux, T. congo-
lense remains viable in significantly lower glucose concentrations, with a reduced flux, again
more similar to PCF T. brucei. However, glucose remains an essential carbon source in this
species, as growth is abolished in the absence of glucose. Of particular interest is whether the
parasite generates the majority of ATP from this reduced glucose intake, or if it can thrive on
other carbon sources such as amino acids or even fatty acids. If the latter, this adaptation could
be due to the reduced bioavailability of glucose in the ruminant host bloodstream. Blood con-
centrations of glucose in humans are approximately 5.5 mM [108]. Glucose concentrations in
ruminants are typically lower (2–4 mM [109–111]), and primary sources of energy are typi-
cally volatile fatty acids in the form of acetic, propionic and butyric acid [112,113]. To date,
products of volatile fatty acid metabolism, such as 2-methylcitrate and 2-methyl-cis-aconitase
have not been reported in T. congolense. However, it is thought T. brucei can metabolise ketone
bodies such as β-hydroxybutyrate through the action of a β-hydroxybutyrate dehydrogenase
(Tb927.10.11930) to generate acetoacetate [114]. T. congolense possesses an orthologue of this
gene (TcIL3000.A.H_000824100), and therefore, the ability of T. congolense to utilise other
products available in adult ruminant blood merits further investigation.
RNAseq analyses of T. congolense indicate high levels of expression of mitochondrial path-
ways associated with glucose catabolism, specifically acetate and acetyl-CoA metabolism
involving PDH, ASCT and succinyl-CoA synthetase (SCS; Fig 8). Given that the large amounts
of acetate generated by the parasite appear not to be required for fatty acid synthesis, these
findings could suggest significant reliance on mitochondrial substrate level phosphorylation
for growth, similar to PCF T. brucei cultured in glucose-rich medium [115,116]. Interestingly,
T. congolense does not appear to encode a syntenic orthologue of MPC1 (S1 Fig), and attempts
reductase, TbTc_1241; 58, Trans-2-enoyl-ACP reductase 1, TbTc_5269; 59, acetyl-CoA synthetase, TbTc_0318; 60, acetyl-CoA carboxylase, TbTc_0754; 61, Fatty acid
elongase (ELO1), TbTc_0159; 62, Fatty acid elongase (ELO2), TbTc_1882; 63, Fatty acid elongase (ELO3), TbTc_0235; 64, elongation of very long chain fatty acids protein
(ELO4), TbTc_0737; 65, aspartate aminotransferase, TbTc_0799; 66, aspartate carbamoyltransferase, TbTc_1630; 67, dihydroorotase, TbTc_3801; 68, dihydroorotate
dehydrogenase, TbTc_0620; 69, orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, TbTc_0735; 70, uracil phosphoribosyltransferase, TbTc_4220;
71, Adenine phosphoribosyltransferase (APRT-2), TbTc_3522; 72, inosine-adenosine-guanosine-nucleoside hydrolase, TbTc_4998; 73, adenosine kinase, TbTc_1024; 74,
AMP deaminase, TbTc_5808; 75, hypoxanthine-guanine phosphoribosyltransferase (HGPRT), TbTc_0726; 76, inosine-guanine nucleoside hydrolase, TbTc_0808; 77,
inosine-5’-monophosphate dehydrogenase, TbTc_1648; 78, Hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT), TbTc_3696; 79, GMP reductase,
TbTc_4627; 80, GMP synthase, TbTc_1452. Abbreviations: PUFA, polyunsaturated fatty acid.
https://doi.org/10.1371/journal.ppat.1009734.g008
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to identify the gene by orthoMCL or Orthofinder were unsuccessful. In T. brucei, the mito-
chondrial pyruvate carrier is composed of two paralogous proteins, MPC1 and MPC2, both of
which are essential [104]. The absence of an MPC1 orthologue in T. congolense, in spite of
these cells requiring mitochondrial pyruvate transport, inferred from acetate production from
glucose, indicates a key difference in the constitution of pyruvate carrier in this species. Struc-
tural differences to pyruvate carriers between the two species, or the enhanced mitochondrial
pyruvate catabolism in T. congolense may explain its enhanced sensitivity to UK5099, a mito-
chondrial pyruvate transport inhibitor. In addition, previous data suggest that in T. brucei,
there is likely another mitochondrial pyruvate carrier that is insensitive to UK5099 [104].
Our data are consistent with the absence of oxidative phosphorylation, based on transcrip-
tomics and lack of sensitivity to chemical inhibition, compared to T. brucei. One previous
study reported NADH dehydrogenase activity in BSF T. congolense, which was presumed to
originate from complex I, indicating potential ATP generation via complex V [51]. However,
T. congolense exhibit significantly reduced sensitivity to rotenone, compared to T. brucei, sug-
gesting that NADH dehydrogenase activity may originate from a rotenone-insensitive NADH
dehydrogenase such as NDH2, known to be important for acetate production in BSF T. brucei
[77,117,118]. This result must be treated with caution, as high concentrations of rotenone can
lead to off-target effects [119]. Sensitivity to the TAO inhibitor SHAM suggests that TAO is
the terminal oxidase, with no significant complex III or IV activity. These conclusions support
one previous study of BSF T. congolense [51], although further work must be carried out to
confirm the roles of complex I and V in this species.
Rather than oxidative phosphorylation, we propose it is more likely that considerable ATP
production occurs in the ASCT–SCS cycle, which would explain the high levels of acetate gen-
erated by T. congolense, in addition to increased sensitivity to inhibition of mitochondrial
uptake of pyruvate, the key metabolic precursor. Given that 2-oxoglutarate dehydrogenase
complex expression appears to be less than, or equal to, that in T. brucei (under in vitro cultur-
ing conditions; Fig 8), it is likely that SCS activity occurs in the acetate-generating pathway
rather than in the TCA cycle, which is not thought to be fully functional in BSF African try-
panosomes [38], although recent data have challenged this paradigm in PCF T. brucei [40].
The mechanisms proposed here bear some similarities to the scheme proposed by Dewar and
colleagues for stumpy-form T. brucei metabolism, which also exhibit increased mitochondrial
metabolism compared to BSF T. brucei [120].
In T. brucei, carbon atoms from glucose disseminate through multiple pathways in the cell
[45] and, using stable isotope-labelled glucose, our data demonstrate that this pattern is also
seen in T. congolense, in particular through the glycolytic pathway, suggesting some of the key
metabolic differences observed are quantitative, rather than qualitative. However, there were
key differences in glucose-derived carbon usage. In particular, a reduction in labelling was
observed in purine nucleotides in T. congolense. In both species, carbon labelling is likely due
to generation of ribose phosphate sugars via the PPP and these data suggest that T. congolense
does not obtain its ribose through the PPP (from glucose), to the same extent that T. brucei
does. Interestingly, T. congolense appears to express higher levels of APRT1 (cytosolic) com-
pared to APRT2 (glycosomal) to synthesise adenosine (Fig 5). This discrepancy could under-
pin the reduced fraction of glucose-derived purine labelling, with a reliance on ribose from
alternative sources (for example, exogenously).
Whilst the majority of pyrimidine labelling is 5-carbons in T. brucei, indicating labelled
ribose, there is decreased 5-carbon labelling and higher abundance of 2-carbon labelling in T.
congolense, likely through uridine generated from aspartate through orotate, again highlighting
a reduction in glucose-derived ribose, but conversely, an increase in glucose-derived UMP and
its derivatives. This study was not able to assess whether T. congolense has a capacity for
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cytosine uptake. It is established that T. brucei does not take up this pyrimidine [121], but
given the expanded nucleobase transporter repertoire in the T. congolense genome [21], it
would be of interest to carry out more in depth analysis of cytosine metabolism, as well as
nucleotide metabolism in general, given the interest in drug development.
There was also a reduced abundance of glucose- and threonine-derived fatty acid labelling
in T. congolense relative to T. brucei. One previous study noted that, like T. brucei, the major
constituent of T. congolense GPI anchors is glycosyl-sn-1,2-dimyristylphosphatidylinositol,
suggesting that this species will have a substantial requirement for myristic acid [98]. However,
lack of glucose- or threonine-derived fatty acid labelling, in addition to decreased transcript
abundance of AceCS, suggests that T. congolense may scavenge exogenous lipids in favour of
carrying out fatty acid biosynthesis. Supernatant metabolomics showed accumulation of both
choline and choline phosphate, with a corresponding decrease in putative LysoPCs, which
appears to indicate activity of the phospholipases that T. congolense is known to secrete
[62,122]. It is unknown whether T. congolense is able to generate cytosolic acetyl-CoA for fatty
acid biosynthesis through the action of citrate lyase, although transcript abundance of this
putative citrate lyase gene was reduced compared to T. brucei. Analysis of drug sensitivity sup-
ports the above conclusions, as T. congolense is significantly less sensitive to acetyl-CoA syn-
thetase inhibition, as well as Orlistat, an inhibitor of fatty acid synthase, suggesting that fatty
acid scavenging (e.g. lipid or fatty acid transporters) could be a viable therapeutic target for
this species. However, the efficacy of orlistat in vivo has not been reported to our knowledge.
BSF T. brucei growth in CMM required only cysteine and glutamine when supplemented
with FBS gold, although a further 6 amino acids (Tyr, Phe, Trp, Leu, Met and Arg) were
required when supplemented with standard FBS [60]. As part of this study, 14 amino acids
essential for T. congolense growth were identified. Tryptophan and arginine, essential to T.
brucei, were not required to sustain T. congolense growth in 10% goat serum. Conversely, sev-
eral amino acids considered not essential to T. brucei were crucial for T. congolense growth in
vitro (Asp, His, Ile, Pro, Ser and Val). Proline is a well-established carbon source for PCF T.
brucei [92]. However, based on stable isotope labelling experiments, this amino acid is solely
used for protein synthesis in BSF T. congolense, as there was no evidence of carbon dissemina-
tion from proline into the metabolome (likewise for asparagine). Unlike BSF T. congolense,
BSF T. brucei must be able to synthesise sufficient amounts of these amino acids from alterna-
tive sources, or obtain them from the serum supplement.
One metabolic area of interest in trypanosomatids is trypanothione biosynthesis, a crucial
pathway for parasite response to oxidative stress. Indeed, trypanothione synthase, as well as
proteins involved in the trypanothione biosynthesis pathway, such as ornithine decarboxylase
(targeted by Eflornithine), have long been considered prime chemotherapeutic targets due to
their absence from other organisms [123]. Whilst cysteine was previously known to be a main
carbon contributor to trypanothione synthesis in T. brucei along with glutamine and methio-
nine [89], we show here that serine, an amino acid essential to T. congolense, also contributes
to the generation of this metabolite in addition to the aforementioned amino acids. These data
indicate that T. congolense can both synthesise and transport cysteine. Interestingly, cysteine
was not significantly depleted from T. congolense culture supernatants and future work should
ascertain whether the presence of L-serine in medium can compensate for reduced cysteine
levels in T. congolense culture.
The data presented here have led to the generation of a novel semi-defined medium for cul-
turing the strain IL3000, which must be further optimized for the culture of multiple strains of
T. congolense. Of interest is the peculiar requirement of adult bovine or goat serum for in vitro
culture of T. congolense, rather than foetal bovine serum (FBS) which is typically used to cul-
ture T. brucei [18,63]. Whilst this study made no attempts to adapt T. congolense to FBS-
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supplemented medium (indeed, even in SCM-7, growth rate is drastically reduced in the pres-
ence of FBS after 2–3 passages), this is of crucial importance, as it would allow the study of
multiple species of African trypanosome under the same in vitro conditions. Analysis of
metabolism presented here indicates that this phenomenon is likely to centre on the lipid
requirements of T. congolense, although it remains to be seen if this requirement is for energy
generation or synthesis of lipids in general. Furthermore, adult ruminant serum composition
drastically differs from that of non-ruminants and of foetal ruminants [112,113], and this likely
has significant implications on the extracellular environment faced by livestock trypanosomes.
The information presented here is a significant step in laying the foundation for fundamen-
tal understanding of metabolism for an important livestock parasite. Understanding essential
areas of metabolism in both T. brucei and T. congolense enables the development of drugs
effectively targeting both species. Conversely, understanding the key differences between the
two species aids in dissecting drug mechanisms of action and resistance, as well as enabling a
greater understanding of host-pathogen dynamics.
Materials and methods
Ethics statement
All animal experiments were performed in accordance with the Animals (Scientific Proce-
dures) Act 1986 and the University of Glasgow care and maintenance guidelines. All animal
protocols and procedures were approved by The Home Office of the UK government and the
University of Glasgow Ethics Committee.
Compounds and reagents
All compounds were obtained from Sigma/Merck with the exception of: Orlistat (Cambridge
Bioscience), oligomycin A (VWR International), diminazene aceturate (Cambridge BioSci-
ence) and FCCP (Abcam).
Cell lines and in vitro culture
In all cases, T. congolense strain IL3000 [51] was used (originally received from Theo Baltz,
University of Bordeaux). For RNAi experiments a T. congolense IL3000 single marker line,
TcoSM, was used [107]. For in vitro experiments, cells were grown at 34˚C, 5% CO2 and rou-
tinely cultured in either TcBSF3 [17] or HMI-93 [18], in both cases without a serum plus sup-
plement, with 20% goat serum (Gibco). For global metabolite analysis of culture supernatant,
an experimental medium (Steketee’s congolense medium-3; SCM-3) was used with the follow-
ing components: 77 mM NaCl, 1.5 mM CaCl2, 4.5 mM KCl, 0.8 mM MgSO4, 36 mM
NaHCO3, 25 mM HEPES, 0.05 mM bathocuproinedisulfonic acid, 0.22 mM 2-mercaptoetha-
nol, 50 U/mL penicillin/streptomycin, 2.5 mM glucose, 1 mM pyruvate, 10% goat serum, 10%
TcBSF3 [17], 1 mM each of L-cysteine and L-glutamine, and 100 μM L-tyrosine, L-phenylala-
nine, L-tryptophan, L-leucine, L-methionine and L-arginine. BSF T. congolense in exponential
growth phase were centrifuged at 1,500 × g for 10 minutes, washed with PBS and inoculated
into this medium (0 h time point).
For stable isotope labelling experiments, as well as experiments involving the removal or addi-
tion of specific medium components, a custom medium, Steketee’s Congolense Medium-6
(SCM-6) was used (S5 Table). The final medium formulation based on this study’s findings,
SCM-7, is provided in S5 Table. This medium is essentially HMI-93, although i) vitamins (with
the exception of folate) were removed, ii) D-glucose concentrations were modified depending on
experimental procedure, but was routinely kept at 10 mM, iii) goat serum levels were reduced to
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10% and, iv) of the 20 amino acids, 14 were added. Increasing the temperature to 37˚C led to a
detrimental effect on cell viability after several passages, as previously reported [18].
For experiments involving T. brucei, either the monomorphic Lister 427 (in vitro experi-
ments and growth curves) or pleomorphic STIB 247 (RNAseq experiments, both in vitro and
ex vivo sample groups) strains were used. Lister 427 cells were grown in HMI-11 [124], whilst
STIB 247 were grown in modified HMI-9 containing 1.1% methylcellulose and 20% serum
plus (Sigma) [125,126]. In both cases, cells were incubated at 37˚C, 5% CO2.
For both species, cell counts were carried out using a haemocytometer, and in the case of T.
congolense, cells were mechanically detached from the culturing plasticware by pipetting prior
to counting. Growth curves were routinely carried out in 2 mL samples incubated in 24-well
plates, resuspended using a P1000. For detachment of cells from flasks, 10 mL plastic pipettes
were used. In cases where cells were harvested for experiments other than those involving
metabolomics, cells could also be detached by replacing the medium with PBS for incubating
at room temperature for several minutes, prior to vigorously tapping the flask to detach
parasites.
RNAi experiments using TcoSM were carried out in HMI-93 in 20 mL cultures. Cells were
seeded at 7 × 105 cells/mL and RNAi induction was initiated with the addition of 1 μg/mL tet-
racycline (Sigma) and 1 × 107 cells were isolated every 24 hours for RNA analysis (outlined
below) before cells were passaged.
Animal experiments
Adult female CD-1 mice (20–30 g body weight; Charles River Laboratories) were infected with
5 × 104 wild-type T. brucei STIB 247 or 1 × 105 wild-type T. congolense IL3000 by intraperito-
neal injection. Parasitaemia was monitored daily by venesection of the lateral tail vein [127].
At first peak of parasitaemia (>107 cells/mL) mice were euthanised and blood isolated. Para-
sites of both species were purified from blood by anion exchange using DEAE cellulose [128].
Purified cells were counted, and a total of 1 × 108 cells were centrifuged for 10 minutes at 1,500
× g prior to RNA extraction.
RNA extraction
For in vitro parasite RNA isolation, samples (108 cells) of both T. congolense (IL3000) and T.
brucei (STIB 247) were taken from actively dividing cultures grown to densities of 1.8–2 × 106
cells/mL. For ex vivo parasite RNA isolation, samples (also 108 cells) were derived from mouse
infections as described above. RNA was extracted using the QIAgen RNeasy kit (Qiagen) with
an on-column DNase treatment step. Sample concentrations were analysed by Nanodrop and
QuBit, and concentrations adjusted to 37 ng/μL of which 80 μL (2.96 μg) was submitted for
RNAseq.
For RNAi time course experiments, cell pellets (107 cells) were resuspended in 1 mL TRIzol
(Invitrogen) and stored at -80˚C. Samples were thawed, 200 μL chloroform was added, samples
were shaken vigorously for 15 seconds and incubated at room temperature for 3 minutes,
prior to centrifugation at 12,000 × g for 15 minutes, 4˚C. The aqueous layer was transferred to
a fresh tube and 500 μL isopropanol and 1 μL Glycoblue (Invitrogen) were added. Samples
were mixed by inverting, incubated at room temperature for 10 minutes and centrifuged at
12,000 × g for 10 minutes at 4˚C. RNA pellet was washed in ice-cold 75% ethanol and centri-
fuged at 12,000 × g for 10 minutes at 4˚C. After air-drying, RNA was resuspended in 20 μL
RNase-free water and concentration adjusted to 100 ng/μL. DNase treatment was carried out
using the Ambion TURBO DNase kit (Applied Biosystems) as per manufacturer’s
instructions.
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Metabolomics sample preparation
For metabolomics analysis of supernatants, 10 mL T. congolense cultures were incubated in
T25 flasks in relevant media. Cells were centrifuged at 1,500 × g for 10 minutes, washed with
PBS, resuspended in relevant media and density adjusted to 1 × 105 cells/mL. At each time-
point, 500 μL medium was transferred to a 1.5 mL Eppendorf tube and briefly quenched in a
dry ice/ethanol bath, before centrifuging at 1,500 × g for 10 minutes at 4˚C. A 5 μL aliquot was
then transferred to a new Eppendorf containing 200 μL metabolite extraction solvent (chloro-
form:methanol:water in a 1:3:1 ratio) and samples vortexed at 4˚C for one hour. Samples were
centrifuged for 5 minutes at 13,000 × g (4˚C) and supernatants transferred to new Eppendorf
tubes. Samples were stored at -80˚C prior to analysis.
For analysis of intracellular metabolites, cells were grown to a final density of 2 × 106 cells/
mL and a total of 108 cells isolated. Cells were quenched in 50 mL falcon tubes to 4˚C using a
dry ice/ethanol bath (stirred and measured by thermometer) and all subsequent steps were car-
ried out at 4˚C. Cells were centrifuged at 1,500 × g for 10 minutes and if supernatant samples
were required in addition to cell pellets, 5 μL was transferred to an Eppendorf containing
200 μL extraction solvent. Cells were resuspended in residual medium before transfer to
Eppendorf tubes. Cells were then centrifuged (1,500 × g, 5 minutes) and washed twice with
ice-cold phosphate buffered saline (PBS) before resuspension in 200 μL extraction solvent
(chloroform:methanol:water in a 1:3:1 ratio). Samples were vortexed at 4˚C for 1 hour, and
then centrifuged for 5 minutes at 13,000 × g. Supernatants were transferred to clean Eppendorf
tubes. For all experiments, a quality control sample was generated by pooling 10 μL from each
sample and samples were stored under argon gas at -80˚C.
Primers and plasmids
RNAi experiments were carried out using a T. congolense single marker line, TcoSM [107] that
expresses Tet repressor and T7 polymerase, maintained in 0.5 μg/mL puromycin, and gene
specific RNAi constructs were introduced with a T. congolense specific plasmid, p3T7-TcoV
[107]. Primers carrying a HindIII (forward) or an FseI (reverse) restriction site were used to
amplify a fragment of TcoHT (fwd: AAGCTTAAACAGAGCAATGCCAGTCG; rev:
GGCCGGCCTTATTACGTTTGGCATTATG; restriction sites underlined). Gene fragments
were amplified using a HiFi polymerase master mix (NEB) and cloned into pGEM-T easy
(Promega) and sequenced to confirm correct sequence identity of each fragment. The con-
structs were then digested with HindIII and FseI and ligated into the p3T7-TcoV vector [107]
using T4 DNA ligase (Promega). The final plasmid was linearised with NotI before purification
by ethanol precipitation prior to electroporation into TcoSM cells.
Transfections/electroporations
T. congolense IL3000 electroporation experiments and selection experiments were performed
as developed by [107]. A total of 4 × 107 cells were used per transfection, including a negative
(buffer only) control. A transfection buffer previously published for use with T. brucei was
used for T. congolense transfections [129]. Cells were centrifuged at 1,500 × g for 10 minutes,
pellets resuspended in residual medium and transferred to Eppendorf tubes for a further cen-
trifugation step. Cells were subsequently washed in transfection buffer prior to final resuspen-
sion in 100 μL buffer per transfection. Up to 12 μg linearised plasmid DNA was added to an
electroporation cuvette (Sigma), and 100 μL cells were subsequently added. Electroporation
was carried out using a Nucleofector II (Lonza) programme Z-001. Transfected cells were then
incubated overnight in 25 mL warm medium in the absence of selective antibiotics, prior to
their addition and plating out at dilutions of 1:50, 1:100 and 1:200 in 96-well plates. Antibiotics
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were added at the following concentrations: Puromycin: 0.5 μg/mL; Neomycin (G418): 0.4 μg/
mL. Clones were retrieved after 7–10 days, and these were maintained in 0.25 μg/mL puromy-
cin and 0.2 μg/mL G418.
Drug sensitivity assays
Drug sensitivity assays were carried out using the alamar blue method developed by Raz and
colleagues [130]. Briefly, Compounds were diluted to 2× starting concentration in SCM-6
(with 10% goat serum for T. congolense IL3000 or 10% FBS for T. brucei Lister 427) and 200 μL
was transferred to the first well of a solid white flat-bottomed 96-well plate. 100 μL medium
was then added to 23 further wells and compounds were diluted 1:2 over this series of wells,
with the exception of the last well, for a negative control. Subsequently, 100 μL cells were
added at 2× starting density (4 × 104 cells/mL for T. brucei and 5 × 105 cells/mL for T. congo-
lense). Plates were incubated for 48 hours (37˚C or 34˚c for T. brucei and T. congolense, respec-
tively, 5% CO2 in both cases), prior to addition of 20 μL resazurin sodium salt (0.49 mM in 1×
PBS, pH 7.4) to each well. Plates were then incubated for a further 24 hours before measure-
ments of cell viability.
Reduction of the resazurin salt was measured as a function of cell viability. Fluorescence of
each plate was read using a Cytation 5 imaging reader (BioTek) and GEN5 software. Parame-
ters were as follows: λexcitation = 540 nm and λemission = 590 nm. Raw values were plotted against
concentrations (converted to log10 values) and normalised (0% defined as smallest mean in the
data; 100% defined as largest mean in the data) using Graphpad Prism version 8.4.0. EC50 val-
ues for each compound were calculated using a non-linear sigmoidal dose-response curve.
Each assay was performed in duplicate and each EC50 value represents a mean of three inde-
pendent experiments.
Real-time quantitative PCR (RT-qPCR)
RNA was extracted as described above, and reverse transcription was carried out in 20 μL
using 1 μg RNA, using a high capacity cDNA kit (Applied Biosystems). Primers for RT-qPCR
analysis were designed using Primer 3 [131], and primer efficiency was tested using serial dilu-
tions of T. congolense IL3000 genomic DNA by plotting Ct value against log10(DNA concentra-
tion). Real-time PCR was carried out using the SensiFAST SYBR Hi-ROX kit (Bioline,
BIO92005). Briefly, a 20 μL reaction was set up using 10 μL SYBR mix, RT template and 400
nM of each primer. Primers targeting all five HT genes were used (TcoHT_fwd: ATAGT
GACGGAGCGGTTCAT; TcoHT_rev: GACGCAACGACACCAATGAT). Cycling conditions
were: 96˚C, 120 seconds, followed by 40 cycles of 95˚C for 5 seconds, 62˚C for 10 seconds and
72˚C for 20 seconds. Previously published endogenous control primers for TcoTERT were
used for within sample normalisation (TcoTert_fwd: TTTCGCCCTCGTTTTCCTCA; Tco-
Tert_rev: AGAAATCACGACCACACGCT) [132], and normalised transcript level was calcu-
lated using the delta delta Ct method [133].
Glucose uptake assays
For analysis of wild-type T. congolense and T. brucei glucose uptake, cells were seeded in 10
mL cultures of SCM-6 at an initial density of 2 × 105 cells/mL (four cultures per species), with
10 mM glucose added separately at the start of the experiment. Upon the addition of glucose, 1
mL supernatant was immediately centrifuged (1,500 × g, 10 minutes) and supernatant stored
at -80˚C. This process was repeated at 12, 15, 18, 21 and 24 h, and cell density measured by
haemocytometer. A medium-only control (4 replicates) was also incubated alongside in vitro
cultures. Glucose concentration of each supernatant sample was analysed using the Glucose
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(GO) assay kit (GAGO-20; Sigma) in a 96-well format. Briefly, 40 μL supernatant sample
(diluted if necessary) was incubated with 80 μL assay reagent for 30 minutes at 37˚C, after
which 80 μL 12 N sulphuric acid was added and absorbance measured at 540 nm using a spec-
trophotometer. A standard curve was also run to calculate glucose concentration. Rate of glu-
cose consumption was calculated using a custom script [61]. Doubling times of T. congolense
IL3000 (11–12 hours) and T. brucei Lister 427 (6–7 hours) were taken into account when cal-
culating rate of glucose consumption.
For glucose consumption of the TcoHT RNAi line, the Glucose Uptake-Glo kit (Promega)
was used. RNAi was induced for 72 hours prior to carrying out the assay. Cells were centri-
fuged, washed in PBS and resuspended in assay buffer (77 mM NaCl, 1.5 mM CaCl2-2H2O, 4.5
mM KCl, 0.8 mM MgSO4-7H2O, 36 mM NaHCO3, 25 mM HEPES and 0.02 mM bathocuproi-
nedisulfonic acid), as it was determined T. congolense viability is reduced in PBS alone. Density
was adjusted to 108 cells/mL, and three 100 μL replicates of each sample were added to wells of
a black flat-bottomed 96-well plate. The uptake reaction was started by the addition of 50 μL 1
mM 2-deoxy-D-glucose. Plate was shaken for 15 minutes at 34˚C prior to addition of 25 μL
stop buffer, 25 μL neutralisation buffer and 100 μL pre-prepared 2DG6P detection reagent.
Plates were shaken in between addition of the buffers. Finally, the plate was read with 0.3–1
second integration on a luminometer (Cytation 5 Imaging reader, BioTek). Wild-type T. con-
golense, and T. congolense supplemented with glucose were used as controls, in addition to
cells without 2-deoxy-D-glucose and assays in the absence of cells.
Acetate concentration assay
Acetate was not detectable by mass spectrometry and therefore, a commercial colorimetric
acetate assay kit (MAK086, Merck) was used to analyse changes in supernatant acetate concen-
trations in trypanosome cultures over time. T. congolense IL3000 were seeded in 10 mL SCM-6
at a density of 1 × 105 cells/mL as outlined in the supernatant metabolomics experiment. At
each time-point, 500 μL supernatant was taken from each flask and transferred to an Eppen-
dorf tube. Samples were centrifuged at 1,500 × g, the supernatant was transferred to a fresh
Eppendorf tube, and samples were stored at -80˚C until samples from all time-points had been
collected. Acetate concentration assays were carried out according to the manufacturer’s
instructions. Briefly, for each sample, 5 μL was added to the wells of a 96-well plate in duplicate
and 45 μL assay buffer was added to each sample. Subsequently, 50 μL reaction mix was added
to each well, and the plate was mixed and incubated for 40 minutes at room temperature
before absorbance was read at 450 nm. Acetate concentrations were calculated using the stan-
dard curve comprised of six concentrations run alongside the experimental samples.
Metabolomics–liquid chromatography mass spectrometry
Hydrophilic interaction liquid chromatography (HILIC) was carried out by Glasgow Polyo-
mics (Glasgow, UK), using a Dionex UltiMate 3000 RSLC system (Thermo Fischer Scientific)
coupled to a ZIC-pHILIC column (150 mm × 4.6 mm, 5 μm column, Merch Sequant). The col-
umn was maintained at 30˚C and samples were eluted with a linear gradient (20 mM ammo-
nium carbonate in water and acetonitrile) over 26 minutes with a flow rate of 0.3 mL/minute.
Sample injection volume was 10 μL and samples were maintained at 4˚C before injection. A
Thermo Orbitrap Exactive (Thermo Fischer Scientific) was used to generate mass spectra, and
was operated in polarity switching mode with the following settings: Resolution: 50,000; AGC:
106; m/z range: 70–1,400; sheath gas: 40; auxiliary gas: 5; sweep gas: 1; probe temperature:
150˚C; capillary temperature: 275˚C. Samples were run in both positive and negative polarity
with the following ionisation: source voltage +4.5 kV, capillary voltage +50 V, tube voltage +70
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kV and skimmer voltage +20 V for positive mode; source voltage -3.5 kV, capillary voltage -50
V, tube voltage -70 V and skimmer voltage -20 V for negative mode. Mass calibration was per-
formed for each polarity immediately prior to each analysis batch. The calibration mass range
was extended to cover small metabolites by inclusion of low-mass contaminants with the stan-
dard Thermo calmix masses (below m/z 1400), C2H6NO2 for positive ion electrospray ionisa-
tion (PIESI) mode (m/z 76.0393) and C3H5O3 for negative ion electrospray ionisation (NIESI)
mode (m/z 89.0244). To enhance calibration stability, lock-mass correction was also applied to
each analytical run using these ubiquitous low-mass contaminants. A set of authentic stan-
dards was run prior to the sample set for each experiment.
Metabolomics data analysis
RAW spectra were converted to mzXML files (mzML files for fragmentation data) using
XCMS for untargeted peak detection [134]. The resultant files were further processed using
mzMatch [135] for peak matching and annotation, resulting in a tabular output that was ana-
lysed using IDEOM with default settings [136]. Identification of metabolites was performed in
Ideom (as previously described by [45]), by matching accurate masses and retention times of
authentic standards (MSI confidence level 1). When standards were not available, predicted
mass and retention time was calculated by a validated model [137] (MSI confidence level 2;
putative annotation based on exact mass determination). Many of the metabolites names given
in the datasets in this study are generated automatically as the Ideom software provides a best
match to public database entries of the given mass and formula. Published literature and path-
way/genome databases were considered to improve annotation in cases where isomers could
not be differentiated based on accurate mass and retention time. Metabolites included in the
manuscript were manually annotated using authentic standards where available. However,
note that many of the metabolite names given in the IDEOM file are generated automatically
as the software provides a best match to database entries of the given mass and formula (S3
Table). In the absence of additional information these must be considered as putatively-anno-
tated hits; the confidence score in the column adjacent to putative metabolite name (S3 Table)
serves as a guide to this. In addition, potential isomers matching the formula are provided in a
drop down list for each metabolite (S3 Table). Clearly it is beyond the scope of any study to
provide authenticated annotations to many hundreds of detected compounds, but the full
datasets are included in the spirit of open access data.
For stable-isotope assisted metabolomics experiments, mzMatch output (in.peakml format)
was analysed using mzMatch-ISO to extract all carbon isotopologue abundances from putative
metabolites [138]. Data analysis of stable isotope-labelled metabolomics was based on a 48
hour time-point in all experiments. Data was further analysed using Microsoft Excel, R or
Metaboanalyst v4.0 [139]. The raw data from all metabolomics analyses are available in Meta-
bolights (accession number: MTBLS2372; URL: www.ebi.ac.uk/metabolights/MTBLS2372).
RNA sequencing and data processing
RNA sequencing was carried out by Edinburgh Genomics (Edinburgh, UK). Libraries were
prepared from 16 samples (8× T. brucei, 8× T. congolense) using the TruSeq Stranded mRNA
kit (Illumina) and 2 × 75 bp paired-end sequencing was carried out using a HiSeq 4000 system
(Illumina). Sequencing reads were aligned to the corresponding genome sequence using
HiSat2 (default settings with “-k 1—no-spliced-alignment” to limit multi-mapping reads to one
alignment) [140]. For T. brucei, the TREU 927 reference genome sequence was used (v51.0
from TriTrypDB [141]), whilst a PacBio assembly of T. congolense IL3000 (2019, v51.0 from
TriTrypDB) was used for T. congolense [142]. The resulting SAM files were converted to BAM
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files using samtools [143], and subsequently filtered for quality (-q 1). Read counts were
extracted from the filtered BAM files using HTSeq-count (“-s reverse -f bam -t CDS -i Parent
-m union -a 0—nonunique-all”). “CDS” was chosen as feature for read counting instead of
“exon”, as UTRs are not annotated in the T. congolense genome, in contrast to the T. brucei
TREU 927 genome, which could lead to further discrepancies during cross-species transcrip-
tome analysis. Read counts are provided in S1 Table.
For all samples, transcripts per million (TPM) values for each gene were calculated manu-
ally from the read count files using Microsoft Excel as follows: 1) Reads per kilobase (RPK)
were calculated by dividing the read counts by the length of gene in kilobases (S1 Table); 2) All
RPK values in a sample were summed and divided by 1 million as a scaling factor (S1 Table);
3) Each RPK value was divided by the scaling factor to yield TPM values [56]. To compare
transcript abundances between the two species, Orthofinder [57] was used to infer orthologue
genes or gene groups. Default parameters were used to compare the T. brucei TREU 927 and
the T. congolense IL3000 annotated proteins (S2 Table). A custom MATLAB (version R2020a)
script was used to combine the Orthofinder dataset and the TPM values for 1-to-1 orthologues,
as well as “sum of TPM” values for groups containing multiple genes, where TPM value for
each gene was summed, resulting in a final dataset (S1 Table). Raw RNA-seq data is deposited
at GEO (accession number: GSE165290). Transcriptomics data were cross-referenced with the
TrypanoCyc database (vm-trypanocyc.toulouse.inra.fr/; [64]) to enable pathway analysis of the
data.
Statistical analysis of the orthoTPM dataset was performed using the limma package in R
[144]. Briefly, genes with an orthoTPM value of< 1 across three or more of the four sample
groups were removed from the dataset (98 genes). The data set was then log-transformed
(log2[TPM+1]) prior to analysis with the eBayes() function including the parameters
“trend = TRUE” and “robust = TRUE”. Statistical output is included in S1 Table.
Computation
Figures were generated using Graphpad Prism version 8.4.0 (www.graphpad.com) with the
exception of scatter plots and heatmaps, which were generated using R [145]. Heatmaps were
generated using the R packages pheatmap and ComplexHeatmap [146]; scatter plots were gen-
erated using GGplot2 and GGally; synteny plots were generated using the python tool MCScan
[147]; pathway maps were generated with Inkscape v1.0.
Supporting information
S1 Fig. Synteny analysis of T. brucei and T. congolense. Plots were generated to assess levels
of synteny between the species in regions where genes appear to be absent in T. congolense. For
3 genes, SDH11 (top), MPC1 (middle) and a putative delta-4 fatty acid desaturase (bottom),
surrounding regions are highly syntenic between T. brucei and T. congolense, indicating that
these are likely 3 deletions from the T. congolense genome. Whilst this does not rule out exis-
tence of these genes in other genomic regions, approaches such as orthoMCL and BLAST did
not yield high probability orthologues in T. congolense.
(TIFF)
S2 Fig. Comparative analysis of published T. congolense RNAseq data and data generated
in this study. Scatter matrix of T. congolense datasets from this study compared to ascending
and peak parasitaemia in vivo transcriptomics data generated by Silvester and colleagues [59].
TPM values were calculated for each gene in the T. congolense genome (S1 Table) and
log2(TPM+1) was plotted. Lower panels: Scatter plots of individual comparisons of the 4
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datasets. Red dots correspond to genes associated with glycolysis, green dots correspond to
genes possessing transmembrane domains that are likely to be transporters; Diagonal panels:
sample names; Upper panels: Pearson correlation coefficients for comparisons of entire data-
sets (black), glycolytic pathway (“Glyc”, green) and proteins with predicted transmembrane
domains (“Trans”, red).
(TIFF)
S3 Fig. Comparative transcriptomics analysis of the electron transport chain in T. congo-
lense and T. brucei. A heatmap of all ETC complexes based on a table generated by Zikova
and colleagues [76]. Heatmaps are divided into the alternative oxidases (AOX), NADH dehy-
drogenase 2 (NDH2), complex I, II, III, IV and ATPase (complex V).
(TIFF)
S4 Fig. Stable isotope labelled (13C)-glucose derived pyrimidine labelling. Comparative
analysis of glucose-derived pyrimidine labelling in T. congolense and T. brucei (taken from
[45]).
(TIFF)
S5 Fig. Effect of cysteine exclusion on T. congolense growth. Parasites were grown in SCM-6
supplemented with 1.5 mM, 1.0 mM or absence of L-cysteine. Cell density was monitored
every 24 hours.
(TIFF)
S6 Fig. Comparison of amino acid metabolism in T. congolense and T. brucei. A) glucose-
derived carbon labelling of amino acids B) Transcriptomics pathway analysis. TrypanoCyc
pathways and gene IDs: A) Arginine and polyamine synthesis (ARG+POLYAMINE-SYN):
SpSyn, spermidine synthase, TbTc_1034; AdoMetDC_3193, AdoMet decarboxylase,
TbTc_3193; ODC, ornithine decarboxylase, TbTc_5903; AdoMetDC_0696, AdoMet decar-
boxylase, TbTc_0696. B) Aspartate and asparagine biosynthesis (ASPASN-PWY): ASNS,
asparagine synthetase, TbTc_4894; mASAT, mitochondrial aspartate aminotransferase,
TbTc_5877; cASAT, cytosolic aspartate aminotransferase, TbTc_0799. C) Glutamate degrada-
tion (GLUCAT-PWY): OGDH-E1, 2-oxoglutarate dehydrogenase E1, TbTc_2864; GDH, glu-
tamate dehydrogenase, TbTc_0872; SUCLG2, succinyl-CoA ligase, TbTc_3392; SCSα,
succinyl-CoA synthetase, TbTc_0813; OGDH-E2, 2-oxoglutarate dehydrogenase E2,
TbTc_3057. D) Isoleucine degradation (ILEUDEG-PWY): ECH, enoyl-CoA hydratase,
TbTc_3283; BCAAT, branched-chain amino acid aminotransferase, TbTc_0559; SCP2,
3-ketoacyl-CoA thiolase, TbTc_4024. E) Leucine degradation (LEUDEG-PWY): ECH, enoyl-
CoA hydratase, TbTc_3283; BCKDHα, 2-oxoisovalerate dehydrogenase α, TbTc_1182; AUH,
methylglutaconyl-CoA hydratase, TbTc_5348; BCKDHβ, 2-oxoisovalerate dehydrogenase β,
TbTc_0682; MCCα, 3-methylcrotonyl-CoA carboxylase α, TbTc_1670; IVDH, isovaleryl-CoA
dehydrogenase, TbTc_3112; SCP2, 3-ketoacyl-CoA thiolase, TbTc_4024; HMGCL, hydroxy-
methylglutaryl-CoA lyase, TbTc_6160; BCAAT, branched-chain amino acid aminotransferase,
TbTc_0559; MCCβ, 3-methylcrotonyl-CoA carboxylase β, TbTc_5385. F) Aspartate super-
pathway (PWY0-781): NADSYN, NAD+ synthase, TbTc_2404; mASAT, mitochondrial aspar-
tate aminotransferase, TbTc_5877; METK1, AdoMet synthase, TbTc_0178; NMNAT,
nicotinamide/nicotinic acid mononucleotide adenylyltransferase, TbTc_4133; cASAT, cyto-
solic aspartate aminotransferase, TbTc_0799; MTR, 5-methyltetrahydropteroyltriglutamate-
homocysteine S-methyltransferase, TbTc_5805. G) Threonine degradation (PWY1V8-11):
AKCT, 2-amino-3-ketobutyrate-CoA ligase, TbTc_6236; TDH, L-threonine dehydrogenase,
TbTc_5991. H) Valine degradation (VALDEG-PWY): ECH, enoyl-CoA hydratase,
TbTc_3283; HOPR, 2-hydroxy-3-oxopropionate reductase, TbTc_2903; BCAAT, branched-
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chain amino acid aminotransferase, TbTc_0559. I) Proline degradation (PROLINE--
DEG2-PWY): ProDH, proline dehydrogenase, TbTc_1591; GDH, glutamate dehydrogenase,
TbTc_0872; P5CDH, delta-1-pyrroline-5-carboxylate dehydrogenase, TbTc1695.
(TIFF)
S7 Fig. Carbon utilisation for trypanothione biosynthesis in T. congolense. Metabolomics
and transcriptomics analyses were carried out to analyse trypanothione biosynthesis. A) A
simplified map of trypanothione biosynthesis as known in T. brucei. Numbers refer to the fol-
lowing enzymes: 1, S-adenosyl-L-methionine synthase, METK1; 2, S-adenosyl-L-methionine
decarboxylase, AdoMetDC; 3, spermidine synthase, SpSyn; 4, methyltransferase reaction,
MTase; 5, S-adenosyl-L-homocysteine dehydrolase, AdoHycase; 6, cystathionine beta
synthase, CBS; 7, cystathione gamma lyase, CTH; 8, glutaminase/amidase, AM; 9, gamma-glu-
tamylcysteine synthetase, GCS; 10, glutathione synthetase, GSS; 11, ornithine decarboxylase,
ODC; 12, spermidine synthase, SpSyn; 13, glutathionylspermidine synthase, GSP; 14, trypa-
nothione synthetase, TRYS; 15, tryparedoxin peroxidase, TXN1b; 16, trypanothione reductase,
TRYR. B) Isotopologue labelling experiments using 100% 13C-L-serine, 13C-L-glutamine,
13C-L-methionine or 13C-L-cysteine, showing the abundance of carbon labelling derived from
these amino acids in components of the trypanothione biosynthesis pathway. C) Transcrip-
tomics analysis. TrypanoCyc pathways and gene IDs: Trypanothione biosynthesis (PWY1V8-
6): AdoMetDC_0696, S-adenosylmethionine decarboxylase, TbTc_0696; GSS, glutathione syn-
thetase, TbTc_3678; AM, amidase, TbTc_5549; AdoMetDC_3193, S-adenosylmethionine
decarboxylase, TbTc_3193; TRYS, trypanothione synthetase, TbTc_1359; ODC, ornithine
decarboxylase, TbTc_5903; TRYR, trypanothione reductase, TbTc_4239; SpSyn, Spermidine
synthase, TbTc_1034; TNX1b, tryparedoxin 1b, TbTc_0324; METK1, S-adenosylmethionine
synthetase, TbTc_0178; GCS, gamma-glutamylcysteine synthetase, TbTc_3424. Homocysteine
degradation/cysteine biosynthesis (HOMOCYSDESGR-PWY1): CBS, cystathionine beta
synthase, TbTc_0413; CTH, cystathione gamma lyase, TbTc_1051. Methionine degradation I
(METHIONINE-DEG1-PWY): AdoHcyase, S-adenosylhomocysteine hydrolase, TbTc_0685;
METK1, S-adenosylmethionine synthase, TbTc_0178.
(TIFF)
S8 Fig. Analysis of LC-MS utilising stable isotope labelled amino acids. Percentage total
labelling of metabolites identified in data from 6 stable isotope labelling experiments using
13C-L-asparagine, 13C-L-cysteine, 13C-L-glutamine, 13C-L-methionine, 13C-L-proline and
13C-L-serine. Colour intensity correlates to the total fraction of the metabolite that was 13C-
labeled.
(TIFF)
S9 Fig. Inhibition of fatty acid synthesis in T. brucei and T. congolense. Sigmoidal dose-
response curves to determine differential sensitivity of the two species of parasite to inhibition
of an ACS inhibitor (panel A) and Orlistat (B).
(TIFF)
S1 Table. RNAseq dataset–T. congolense ex vivo, T. congolense in vitro, T. brucei ex vivo, T.
brucei in vitro, Silvester et al. [59] dataset. Separate worksheets include the final OrthoTPM
dataset, raw read counts (HTSeq-count output), RPK counts, scaling factors and TPM counts
for each sample aligned to its respective genome. A legend is provided in the first worksheet.
(XLSX)
S2 Table. Orthofinder output comparing T. congolense IL3000, T. congolense IL3000 2019,
T. brucei TREU 927 and other trypanosomatids. Further worksheets include lists of genes
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present in only T. brucei or only T. congolense, with no orthologue detected in the other.
(XLSX)
S3 Table. Supernatant metabolomics dataset for in vitro cultured T. congolense over a
period of 56 hours. Metabolites highlighted in yellow were confidently predicted (MSI
level 1) using a set of metabolite standards run alongside the experimental samples. Where
applicable, a list of potential isomers based on matching formula is provided. Note that confi-
dence value only applies to the original metabolite identified by the IDEOM software. Results
of statistical analysis by means of a one-way repeated measures ANOVA (false discovery rate-
adjusted P value, FDR) is also shown for metabolites that were taken forward for downstream
analysis. Further details for each column are provided in a separate worksheet in the same
excel file.
(XLSX)
S4 Table. TrypanoCyc pathways and linked Orthogroup (TbTc) gene IDs.
(XLSX)
S5 Table. Formulation of Steketee’s congolense medium (SCM)-6 & -7.
(XLSX)
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